НОВЫЕ СОЕДИНЕНИЯ И ИХ ИСПОЛЬЗОВАНИЕ В МЕДИЦИНЕ, СПОСОБ ИХ ПОЛУЧЕНИЯ И СОДЕРЖАЩИЕ ИХ ФАРМАЦЕТИЧЕСКИЕКОМПОЗИЦИИ

... 1. Соединения формулы (I), в которой R1 и R2 могут быть одинаковыми или разными и независимо обозначают водород, галоген, нитро, циано, амино, гидрокси или необязательно замещенную группу, выбранную из алкила, циклоалкила, алкокси, циклоалкокси, арила, аралкила, алкилкарбонила, алкокси карбонила, арилкарбонила, арилоксикарбонила, аралкоксикарбонила, гетероарилкарбонила, арилокси, аралкокси, алкилкарбонилокси, алкоксикарбониламино, арилоксикарбониламино, аралкоксикарбониламино, гетероарилкарбонилагпто, гетероарила, гетероаралкила, гетероциклила, гетероаралкокси, гетероарилокси, флуоренилметоксикарбонила (Fmoc), флуоренилметоксикарбониламино (N-Fmoc), -OSO2R8, -OCONR8R9, NR8COOR9, -NR8COR9, -NR8R9, -NR8SO2R9, -NR8 CONR9R10, -NR8CSNR8R9, -SO2R8, -SOR8, -SR8, -SO2NR8R9, -SO2OR8, -CONR8R9, -COOR9 или -COR9, где R8, R9 и R10 могут быть одинаковыми или разными и независимо обозначают водород, необязательно замещенную группу, выбранную из алкила, арила, аралкила, арилокси или гетероарила; или R1 ...

НАФТОКСАЗИНЫ И СПОСОБ ИХ ПОЛУЧЕНИЯ, ИХ ПРИМЕНЕНИЕ ДЛЯ ПРОИЗВОДСТВА МЕДИКАМЕНТОВ И СОДЕРЖАЩАЯ ИХ ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ

Предложены нафтоксазины, способ их получения, их применение для производства медикаментов и их фармацевтическая композиция, проявляющие активность агониста 1D рецепторов серотонина.

RESORUFIN-DERIVATE SOWIE VERFAHREN ZU DEREN HERSTELLUNG.

Verfahren zur Herstellung von 7-Hydroxy-actinomycinen

New polycyclic organic radicals e.g. useful in biochemistry, magnetic materials, electrically conductive materials, superconductors, analysis, oligomers and polymers

Polycyclic organic radicals (I) are new. Polycyclic organic radicals (I) of formula (Ia)-(Ic) are new. X = N, As or P; Y = O, S, Se or NR; R = optionally substituted alkyl or aryl; R<1>-R<16> = H, optionally substituted alkyl, cycloalkyl, aryl or heteroaryl, or N-, O-, S- or P-containing groups, and A, B, C', D = carbocyclyl or heterocyclyl.

DIAGNOSTISCHES IN-VITRO-MITTEL ZUM NACHWEIS VON GLYCOSIDISCHE BINDUNGEN SPALTENDEN ENZYMEN

Light emitting composition and device

AMIDINE COMPOUNDS

... 1474364 Bis-pyrolidinyl tricyclic compounds BRISTOL-MYERS CO 28 Jan 1976 03360/76 Heading C2C Novel compounds of Formula I wherein X is a sulphur or oxygen atom, or a divalent methylene radical of the formula -C(Z 1 Z 2 )- wherein Z 1 and Z 2 are each independently a hydrogen atom or a straight chain lower alkyl group containing from 1 to 4 carbon atoms inclusive; Y is a hydrogen or halogen atom, a trifluoromethyl group, a lower alkyl group containing from 1 to 4 carbon atoms or a lower alkoxy group containing from 1 to 4 carbon atoms and R is a hydrogen atom or a straight chain lower alkyl group containing from 1 to 4 carbon atoms inclusive; or a pharmaceutically acceptable acid addition salt thereof are prepared by reacting a compound of Formula II with a compound of Formula III and POCl 3 or with 2-chlorro-1-(1-pyrolin-2-yl)- 2-pyrroline hydrochloride and optionally converting the product to a salt. Pharmaceutical compositions in conventional forms for oral and parenteral administration ...

Phenoxyazinyl and acridanyl aminocyclopropanes

... 1,137,425. Phenoxazine and acridan derivatives. SMITH KLINE & FRENCH LABORATORIES. 22 July, 1966 [23 July, 1965 (2)], No. 33211/66. Heading C2C. Novel compounds of Formula I, in which Y is oxygen or =CR 3 R 4 , R 3 and R 4 being hydrogen or C 1-3 alkyl, R is hydrogen, chlorine, bromine, trifluoromethyl, methyl, methoxy or methylthio, each of m and n is 0 or 1, each of R 1 and R 2 is hydrogen or C 1-3 alkyl or R 1 and R 2 , together with the nitrogen atom to which they are attached, represent a 1-pyrrolidinyl, piperidino or 4-methyl-1-piperazinyl ring, and their pharmaceutically acceptable acid addition salts are prepared as follows: (a) the compounds in which m is 0 and n is 1 are prepared by reacting a compound of Formula II with a compound of Formula III and reducing the resulting amide of Formula IV; the compounds where m and n are 1 and -NR 1 R 2 represents a tertiary amino group are prepared by reacting a compound of Formula II with an active ester derivative of an aminocyclopropyl ...

Manufacture of a new imidazoline

... 2 - [Phenoxazinyl - (N) - methyl] - imidazoline and its salts are made by condensing reactive esters of 2-oxymethylimidazoline with phenoxazine or its N-metal derivatives (e.g. sodium). The reactive ester may be a halide or alkyl- or aryl-sulphonate, preferably in the form of a salt. A diluent and/or condensing agent may be present. The product forms salts with acids such as hydrochloric, sulphuric, phosphoric, acetic, methane sulphonic and toluene sulphonic. The example shows the reaction between phenoxazine and 2-chloromethyl-imidazoline hydrochloride. According to the Specification as open to inspection under Sect. 91, the phenoxazine nucleus may contain substituents such as methyl, ethyl, methoxy, ethoxy, propyloxy, butyloxy, benzyloxy, acetoxy, benzoyloxy, amino or nitro groups or halogen atoms. The imidazoline nucleus may also be substituted, e.g. with methyl, ethyl or propyl groups. An alternative method of preparation is to react a phenoxazinyl-(N)-acetic acid or derivative thereof ...

New phenthiazine dithiocarboxylates and processes for their preparation

The invention comprises phenthiazine dithiocarboxylates of the general formula (I) and their acid addition and quaternary ammonium salts, wherein X and Y are hydrogen or halogen atoms or alkoxy or alkylthio groups, A is a saturated straight or branched chain divalent aliphatic hydrocarbon group containing 2 to 5 carbon atoms, unsubstituted or substituted by a group B being a single bond or -CH2-, and R1 and R2 are the same or different alkyl groups containing not more than 4 carbon atoms or form with the adjacent nitrogen atom a heterocyclic group, or R1 together with the adjacent nitrogen atom forms with the whole or part of A or B, when -CH2-, a heterocyclic group and R2 is a hydrogen atom or an alkyl group), and a process for the manufacture thereof by reacting a phenthiazine-10-dithiocarboxylate of the general formula (II) (wherein M is an alkali metal atom) with an aminoalkyl halide of the general formula (III) ...

Substituted aralkyl derivatives

Substituted aralkyl derivatives.

New N.N'-substituted diamino-ethanes and their preparation.

Substituted aralkyl derivatives

Substituted aralkyl derivatives

NEW MATERIALS FOR ORGANIC ELECTRICAL LUMINESCENCE DEVICES

AROMATIC HYDRAULIC XY OR THIOL DERIVATIVES OF CARBONIC ACID ESTERS AS LIPASESUBSTRATE.

Procedures for the production of N, N' substituted Diaminoäthanverbindungen

Inhibitors of histone deacetylase

This invention relates to compounds for the inhibition of histone deacetylase. More particularly, the invention provides for compounds of formula (I) wherein (B), Q, J, L and Z are as defined in the specification.

Crystalline r- guanidines, arginine or (l) -arginine (2(s)) -2- ethoxy -3-(4- (2-(10(h) -phenoxazin -10-yl)ethoxy}phenyl)propanoate

Novel polymorphic forms of an antidiabetic agent: process for their preparation and a pharmaceutical composition containing them

PHENOTHIAZINE AND PHENOXAZINE DERIVATIVES, PROCESS AND MARKING SYSTEMS

PHENOTHIAZINE AND PHENOXAZINE DERIVATIVES, PROCESS AND MARKING SYSTEMS

PHENOTHIAZINE AND PHENOXAZINE DERIVATIVES PROCESSES AND MARKING SYSTEMS 3-(N-R2-N-Acylamino)-7-(N-R3-N-R4-amino)-10-acyl-phenothiazines and phenoxazines useful as color formers, particularly in electrochromic recording systems, are prepared by the interaction of the corresponding 3-(N-R2-amino)-7-(N-R3- N-R4-amino) phenothiazinium or phenoxazinium halide with a reducing agent to obtain the corresponding leuco compound and subsequently interacting the leuco compound with at least two molecular proportions of an acylating agent.

LISOFYLLINE ANALOGS AND METHODS FOR USE

The present invention provides analogs of formula (I) of a Lysofylline (LSF), and synthetic methods for the preparation of such analogs. The have the active side chain moiety (5-R-hydroxyhexyl) of LSF and can have greater potency and oral bioavailability than LSF. The compounds (II) are used to treat diabetes, inflammatory and autoimmune conditions. wherein R1 is hydrogen or a group having the formula -C(=O)R3, wherein R is lower alkyl, and R2 is selected from the group consisting of.

AN IMPROVED PROCESS FOR THE PREPARATION OF NEW ANTIDIABETIC AGENTS

The present invention relates to an improved process for the preparation of novel antidiabetic compounds having formula (1) where R1 represents hydrogen or lower alkyl group and X represents hydrogen or halogen atom.

3-ARYL PROPIOLONITRILE COMPOUNDS FOR THIOL LABELING

The present invention relates to a process for labeling compounds comprising thiol moieties with 3-arylpropiolonitrile compounds, to 3-arylpropiolonitrile compounds substituted with tag moieties and to specific 3-arylpropiolonitrile linkers.

NOVEL TRICYCLIC COMPOUNDS AND THEIR USE IN MEDICINE; PROCESSFOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Novel .beta.-aryl-.alpha.-oxysubstituted alkylcarboxylic acids of formula (I) and compositions containing them. The compounds have hypolipidemic, antihyperglycemic uses.

Verfahren zur Herstellung eines neuen Imidazolins.

Verfahren zur Herstellung eines neuen Imidazolins.

Verfahren zur Herstellung einer a-(o-Amino-aryloxy)-fettsäure.

Procédé pour l'aminoalkylation d'amines secondaires aromatiques ou aromatiques hétérocycliques

(A) 3,1-Benzothiazines and 3,1-benzoxazines of gen. formula (I), where A = O or S R = H, alkyl, cycloalkyl, alkenyl, cycloalkenyl aryl, aralkyl, or

... (A) 3,1-Benzothiazines and 3,1-benzoxazines of gen. formula (I), where A = O or S R = H, alkyl, cycloalkyl, alkenyl, cycloalkenyl aryl, aralkyl, or lower dialkylaminoalkyl in which the dialkylamino group can also be cyclized via O, S, or methyl- or benzylimino, R1 = H, halogen, methoxy, CF3, NO2 R2 = alkyl, aralkyl, or aryl, in which the benzene rings of the last two can be substituted by halogen, methoxy, CF3, NO2. (B) Salts of I formed with organic and inorganic acids. Compounds (1) combine valuable pharmacological properties with very low toxicity. They are central depressants, as well as stimulants, sedatives, noradrenaline potentiators, analgesics and spasmolytics, and they prolong narcosis. They are useful in the treatment of mental diseases, e.g. depression, psychioneuroses, disturbances and anxiety states of neurotic and psychotic patients.

Verfahren zur Herstellung von heterocyclischen Aldehyden

PROCEDE DE PREPARATION D'AGENTS ANTI-INFLAMMATOIRES.

Procédé de préparation de nouveaux dérivés de la phénoxazine

Verfahren zur Herstellung von N,N'-substituierten Diaminoäthanverbindungen

Procédé de préparation de nouveaux dérivés de la phénoxazine

Procédé de préparation de nouvelles phénothiazines

Verfahren zur Herstellung von neuen antidiabetisch wirksamen Sulfonyl-harnstoffen bzw. -semicarbaziden

Antidiabetic sulphonyl ureas and sulphonyl

Sulphonyl ureas and -semicarbazides of (I) X = -O or -S, satd. or unsatd., straight- or branched alkylene group (C1 - C3); oxymethylene, thiamethylene, thiaethylene, opt. alkylated or acylated iminomethylene, opt. alkylated carboximido or a valency bond. R1 = H, halogen, alkyl, alkoxy or CF3; Y = satd. or unsatd., straight- or branched alkylene (C1 - C6) which may contain an N- or -O atom; Z = straight- or branched alkylene (C1 - C4); R2 = satd. or unsatd., straight- or branched alkyl- or cycloalkyl residue opt. interrupted by S or O or containing an endoalkylene group, opt. substd. aryl or aralkyl residue or opt. substd., satd. or unsatd. alkylene imino residue (C3 - C7) which may contain an endoalkylene group (I) have anti-diabetic activity.

Verfahren zur Herstellung von N,N'-substituierten Diaminoäthanverbindungen

Verfahren zur Herstellung von N,N'-substituierten Diaminoäthanverbindungen

Verfahren zur Herstellung von N,N'-substituierten Diaminoäthanverbindungen

Verfahren zur Herstellung von N,N'-substituierten Diaminoäthanverbindungen

Verfahren zur Herstellung von N,N'-substituierten Diaminoäthanverbindungen

Verfahren zur Herstellung von neuen antidiabetisch wirksamen Sulfonylharnstoffen bzw. -semicarbaziden

Process for the preparation of bispyrrolinyl derivatives of phenothiazines, phenoxazines and acridans

Bispyrrolinyl derivatives of phenothiazines, phenoxazines and acridans are obtained by reacting a phenothiazine, phenoxazine or acridan with a pyrrolidinone in the presence of phosphorus oxychloride. The phenothiazine, phenoxazine or acridan can likewise be converted by alkylation with 2-chloro-1-(1-pyrrolin-2-yl)-2-pyrroline into the required compounds. Typical examples of these bispyrrolinyl derivatives are 2-methoxy-10-[5-methyl-1-(5-methyl-1-pyrrolin-2-yl)-2-pyrrolin-2-yl]-p henothiazine, 10-[1-(1-pyrrolin-2-yl)-2-pyrrolin-2-yl]phenoxazine and 9,9-dimethyl-10-[5-methyl-1-(5-methyl-1-pyrrolin-2-yl)-2-pyrrolin-2-yl ]acridan. The amidine compounds can be used as diuretics, smooth muscle relaxants and antithrombogenic agents.

Diaryl (thio)ether prepn.

Diaryl (thio)ether prepn. by reacting alkali metal phenate with a halo or nitro aryl cpd. having an electron fixing gp. in a two phase system with a quat. catalyst ...

Microbicides

Novel compounds of the formula I are described in which A denotes oxygen, sulphur, -CH2-, -CH2CH2- or -CH=CH- and the remaining substituents have the meanings given in Claim 1. Such compounds can be used for controlling microorganisms, in particular against phytopathogenic fungi and bacteria. Compounds of the formula I have a curative, preventive and systemic activity for the protection of crop plants which is highly favourable for practical requirements, without affecting the crop plants by undesired side effects. They can in practice be used by themselves or in the form of compositions.

SUBSTITUTED ARALKYL DERIVATIVES OF

CHARGE TRANSPORT MATERIAL, INK COMPOSITION USING SAID MATERIAL, ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY ELEMENT, LIGHTING DEVICE AND DISPLAY DEVICE

Red light emitted compound used for organic electroluminous device and orgainic electroluminous device using same

Phénothiazines and phenoxazines carrying a substituent bicyclic

Phenoxazine, phenothiazine deriv - esp aminoethoxyethoxycarbonyl subst deriv antitussives, bronchodilators, antiinflammatories

Anthracene derivative compound and an organic light emitting device comprising the same

NEW TRIPHENYLENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAID DERIVATIVE

유기 전계발광 소자용 페녹사진 유도체

... 본 발명은 화학식 (1) 및 (2) 의 화합물, 및 유기 전계발광 소자, 특히 이들 화합물이 방사층에서 호스트 재료 또는 도판트로서 및/또는 정공 수송 재료로서 및/또는 전자 수송 재료로서 사용되는 청색-방사 소자에 관한 것이다.

유기 전계발광 소자용 재료

... 본 발명은 전자 소자, 특히 유기 전계발광 소자에서 사용하기에 적합한 화학식 (1) 의 화합물, 및 상기 화합물을 함유하는 전자 소자에 관한 것이다.

ORGANIC COMPOUNDS

The invention relates to novel diamines of the formula (I) in which all variables are as defined in the specification, in free base form or in acid addition salt form, to their preparation, to their use as medicaments and to medicaments comprising them. © KIPO & WIPO 2008 ...

Novel organic electroluminescent compounds and organic electroluminescent device using the same

Disclosed are novel organic electroluminescent compounds and organic electroluminescent devices comprising the same. More particularly, the organic electroluminescent compounds are represented by Chemical Formula (1): With good luminous efficiency and excellent color purity and life property, the organic electroluminescent compounds according to the invention can be used to manufacture OLED devices having very good operation life.

PROCESS OF MAKING 3-PHENYLIMINO-3H-PHENOTHIAZINE OR 3-PHENYLIMINO-3H-PHENOXAZINE MEDIATOR

A method of forming a 3-phenylimino-3H-phenothiazine or a 3-phenylimino-3H-phenoxazine mediator includes providing a first reactant including phenothiazine or phenoxazine, providing a first solvent, providing a second reactant and providing a second solvent. The first reactant, first solvent, second reactant and second solvent are combined to form a reactants solution. Sodium persulfate is added to the reactants solution to couple the first and second reactants resulting in a reaction solution including the 3-phenylimino-3H-phenothiazine or the 3-phenylimino-3H-phenoxazine mediator.

FLUORINATED RESORUFIN COMPOUNDS AND THEIR APPLICATION IN DETECTING HYDROGEN PEROXIDE

The invention provides novel fluorinated resorufin compounds having the general in which at least one of Rb, Rc, Re, Rf, Rhet Ri is fluorine; Rd represents Ord1 ou NRd1Rd2; Rg represents ORg1, NRg1Rg2 ou (=O); X is oxygen or sulfur; that are of use in a variety of assay formats. Also provided are methods of using the compounds and kits that include a compound of the invention and instructions detailing the use of the compound in one or more assay formats.

Fluorinated resorufin compounds and their application

The invention provides novel fluorinated resorufin compounds that are of use in a variety of assay formats. Also provided are methods of using the compounds and kits that include a compound of the invention and instructions detailing the use of the compound in one or more assay formats.

Oxazine-ureas and thiazine urea chromophors

Novel adducts of oxazine urea chromophors or thiazine urea chromophors with organic substrates are provided which are useful in analytical techniques for the detection and measurement of biological and clinical compounds of interest.

Oxazine dyes, their preparation and the use thereof

The compounds of formula wherein the substituents are as defined in the claims, are suitable for dyeing or printing, inter alia, polyacrylonitrile and acid-modified polyester fibers, and can furthermore be converted by anion exchange into a physical form suitable for liquid formulations.

Enzymatic substrates derived from phenoxazinone and their use as developer in detection of microorganisms with peptidase activity

Novel enzymatic substrates of the general formula below: reaction media containing the same and their use for detecting and/or identifying and/or quantifying microorganisms expressing at least one peptidase activity.

PHENOXAZINE DERIVATIVES FOR ORGANIC ELECTROLUMINESCENT DEVICES

The present invention relates to the compounds of the formula (1) and to organic electroluminescent devices, in particular blue-emitting devices, in which these compounds are used as host material or dopant in the emitting layer and/or as hole-transport material and/or as electron-transport material. 119-. (canceled)21. The compound of claim 20 , wherein Ais Arand a+b=0 or 1 and/or Ais Arand c+d=0 or 1.22. The compound of claim 20 , wherein E is on each occurrence claim 20 , identically or differently claim 20 , a divalent bridge selected from the group consisting of C(R) claim 20 , Si(R) claim 20 , O claim 20 , and S claim 20 , or E is a group of formula (E-1).23. The compound of claim 20 , wherein both Aand Aare Arand a+b=0 or 1 and c+d=0 or 1.25. The compound of claim 20 , wherein Aris selected claim 20 , identically or differently claim 20 , from the group consisting of aromatic and heteroaromatic ring systems having 5 to 14 aromatic ring atoms claim 20 , which are optionally substituted by one or more radicals R.27. The compound of claim 26 , wherein at least one 6-membered ring in the para position to the O atom of the central ring of the phenoxazine structure comprises two adjacent groups V which are a group of the formula (8a) or (9a).28. The compound of claim 26 , wherein at least one group V is CR claim 26 , wherein Ris selected from the group consisting of N(R)and aromatic or heteroaromatic ring systems having 5 to 30 aromatic ring atoms claim 26 , which in each case is optionally substituted by one or more radicals R.30. The compound of claim 20 , wherein Aris selected claim 20 , identically or differently claim 20 , from the group consisting of an aryl and heteroaryl groups having 5 to 18 aromatic ring atoms claim 20 , which are optionally substituted by one or more radicals R.31. The compound of claim 20 , wherein Ris on each occurrence claim 20 , identically or differently claim 20 , a straight-chain alkyl having 1 to 20 C atoms or a branched or ...

3-aryl propiolonitrile compounds for thiol labeling

The present invention relates to a process for labeling compounds comprising thiol moieties with 3-arylpropiolonitrile compounds, to 3-arylpropiolonitrile compounds substituted with tag moieties and to specific 3-arylpropiolonitrile linkers.

Phenoxazine polymer compound and light emitting device using the same

A polymer compound comprising a residue of a compound represented by the following formula (0): wherein Ar0 represents a substituent such as a hydrogen atom, an alkyl group, an alkoxy group, an aryl group and the like, or a group represented by the following formula (A), at least two Ar0s are groups represented by the following formula (A), R0 represents a substituent such as an alkyl group, an alkoxy group, an aryl group and the like, l and m represent an integer of 0 to 3, wherein A0 represents -N= or -C(R2)=. R2 represents a substituent such as a hydrogen atom, an alkyl group, an alkoxy group, an aryl group and the like.

MODIFIED ACTINOMYCIN-BASED NUCLEIC ACID STAINS AND METHODS OF THEIR USE

Actinomycin-based near IR emitting compounds and methods of their use as nucleic acid stains are provided.

Methods, systems, and apparatus for the monitoring, controlling, and communicating of electronic devices

Methods, systems, and apparatus for monitoring and controlling electronic devices using wired and wireless protocols are disclosed. The systems and apparatus may monitor their environment for signals from electronic devices. The systems and apparatus may take and disambiguate the signals that are received from the devices in their environment to identify the devices and associate control signals with the devices. The systems and apparatus may use communication means to send control signals to the identified electronic devices. Multiple apparatuses or systems may be connected together into networks, including mesh networks, to make for a more robust architecture.

Phosphatase Binding Compounds and Methods of Using Same

The present invention provides bifunctional compounds that efficiently dephosphorylate certain phospho-activated target proteins. Such target proteins can be any protein involved in the pathway of a disease or disorder, such as but not limited to cancer, neurodegeneration, metabolic disease, diabetes, insulin resistance, and so forth.

Condensed cyclic compound and organic light-emitting device including the same

A condensed cyclic compound represented by Formula 1: Ar1-(L1)a1-Ar2 Formula 1 wherein, in Formula 1, a1, Ar1, Ar2, and L1are the same as described in the specification.

TRICYCLIC COMPOUND, AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF

A tricyclic compound having the structure represented by general formula (I), a pharmaceutical composition thereof, a preparation method therefor and the use thereof in the prevention and treatment of a variety of diseases caused by toxic aldehydes.

N-Acyldihydroresorufin derivatives, process for their preparation as well as their use for the determination of hydrogen peroxide, peroxidatically active compounds, or peroxidase

The present invention provides N-acylidihydroresorufin derivatives of the general formula: (I) wherein R1 is a lower alkyl, aryl or aralkyl radical, which can be substituted by carboxyl or sulphonic acid residues, R2, R3 and R4, which can be the same or different, are hydrogen or halogen atoms or lower alkyl or lower alkoxy radicals, Y is an -NR5R6 or -OR7 group, wherein R5 and R6 are, in each case, hydrogen atoms or lower alkyl radicals, which can be substituted by carboxyl or sulphonic acid residues, or together represent a hydrocarbon bridge optionally interrupted by hereto atoms and R7 is a lower alkyl radical which can be substituted by a lower alkoxy or poly-lower alkoxy radical.

НОВЫЕ ПОЛИМОРФНЫЕ ФОРМЫ АНТИДИАБЕТИЧЕСКОГО СРЕДСТВА, СПОСОБ ИХ ПОЛУЧЕНИЯ И СОДЕРЖАЩИЕ ИХ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ

... 1. Полиморфная форма I L-аргининовой соли (2S)-3-[4-[2-(феноксазин-10-ил)этокси]фенил]-2-этоксипропановой кислоты формулы I характеризующаяся следующими параметрами: DSC: эндотермический пик термограммы при 181,21°С (начало при 177,70°С); порошковая рентгенография (2Θ): 8,18, 12,40, 16,66, 18,80, 19,44, 22,32, 22,84, 23,10, 23,50, 24,72, 29,84; полосы поглощения инфракрасного излучения (см-1): 3249, 3062, 1709, 1587, 1489, 1374, 1272, 1243, 1112, 1043, 919, 737, 673, 543. 2. Полиморфная форма II L-аргининовой соли (2S)-3-[4-[2-(феноксазин-10-ил)этокси]фенил]-2-этоксипропановой кислоты формулы I характеризующаяся следующими параметрами: DSC: эндотермические пики термограммы при 131°С, 166,24°С и 178,96°С, экзотермический пик термограммы при 169,73°С; порошковая рентгенография (2Θ): 6,78, 11,5, 12,08, 16,44, 19,34, 22,30, 22,72, 24,40, 26,66; полосы поглощения инфракрасного излучения (см-1): 3055, 1711, 1589, 1510, 1491, 1376, 1274, 1111, 1039, 810, 730, 543. 3. Полиморфная форма III L-аргининовой ...

ИНГИБИТОРЫ ГИСТОНОВОЙ ДЕАЦЕТИЛАЗЫ

... 1. Соединение, представленное формулой (I) ! ! и его N-оксидами, гидратами, сольватами, фармацевтически приемлемыми солями, пролекарствами и комплексами, и рацематическими смесями, диастереомерами и энантиомерами, где Z выбран из группы, включающей -N(R1)OR2 и H; ! L выбран из группы, включающей ковалентную связь и -N(OR2)-; ! где, когда L представляет собой -N(OR2)-, Z представляет собой H; и где, когда Z представляет собой H, L представляет собой -N(OR2)-; ! J выбран из группы, включающей ковалентную связь, =CH-, -C1-C8алкил-, -C0-C3алкил-C1-C8гетероалкил-C0-C3алкил-, -C0-C6алкил-C2-C8алкенил-C0-C3алкил-, -C0-C3алкил-C2-C8алкинил-C0-C3алкил-, -C0-C6алкил-арил-C0-C6алкил-, -C0-C6алкил-арил-C2-C6гетероалкил-, -C0-C3алкил-Cl-C6гетероалкил-арил-C0-C6алкил-, -C0-C3алкил-Cl-C6гетероалкил-гетероарил-C0-C6алкил-, -C0-C6алкил-циклоалкил-C0-C6алкил-, -C0-C6алкил-гетероциклил-C0-C6алкил-, C4-C6гетероциклил-арил-C0-C6алкил-, C4-C6гетероциклил-арил-C0-C6гeгетероалкил-, -C0-C6алкил-C4-C6гетероциклил-C0 ...

Способ получения производных резазурина или резоруфина в виде таутомеров

Изобретение касается гетероциклических соединений и, в частности, способа получения производных резазурина или резоруфина в виде таутомеров общих формул @ где R1- H, галоген, C1-C5-алкил, C1-C5-алкоксикарбонил или C1-C5-алкоксил R2и R5-H, галоген или C1-C5-алкил, R3и R4- H, галоген, C1-C5-алкил, C1-C5-алкоксикарбонил, C1-C5-алкоксигруппа, карбоксигруппа или CO-морфолиногруппа R6- H, галоген, карбоксил, C1-C5-алкил, C1-C5-алкоксикарбонил, C1-C5-алкоксигруппа, NO2, сульфогруппа или группа формулы - C(O)O-C2H4-O-C2H4-OC2H5или -C(O)-NH(C2H5) Y - азот или группа NO, причем все радикалы от R1до R6одновременно не водород, если Y - азот, - полупродуктов для синтеза новых индикаторных ферментов для обнаружения гликозидаз. Цель изобретения - создание новых полупродуктов для синтеза новых активных веществ. Синтез целевых веществ ведут реакцией соединений общих формул R1C=C(NO)-C(OH)=CR3-C(OH)=CR2и R6C=CR5-C(OH)=CR4-C(OH)=CH, где R1-R6- см.выше, в присутствии пиролюзита и серной кислоты в спиртовой ...

BUTTERSÄUREDERIVATE, VERFAHREN ZU DEREN HERSTELLUNG, PHARMAZEUTISCHE ZUSAMMENSETZUNGEN, DIE DIESE ENTHALTEN, UND THERAPEUTISCHE ANWENDUNGEN DAVON

Elektrophotographisches Aufzeichnungsmaterial

NATI-INFLAMMATORY AGENTS

... 1388054 Benzoxazinones, benzothiazinones and their monaoaza-analogues; indolinones E R SQUIBB & SONS Inc 5 June 1972 [28 June 1971] 26099/72 Heading C2C The invention comprises compounds of formula and their pharmaceutically acceptable salts and N-oxides, wherein X is H, halogen, alkyl, haloalkyl, haloalkoxy, haloalkylthio, alkoxy, OH, NO 2 , NH 2 , alkylthio, alkylsulphonyl, alkanoylamino or mono- or di-alkylamino, wherein each of the (possibly substituted) alkyl groups contains up to 8 carbon atoms; m is 0-4; each A is CH (but one A may be N when n is 1); Y is S, SO, SO 2 or O; n is 0 or 1; R is C 1-8 alkyl, C 3-8 cycloalkyl, X-substituted Ph, pyridyl, thienyl, furyl, naphthyl (C 1-4 -alkyl)phenyl or (C 2-4 - alkenyl)phenyl; Z is CO, C(OH)R1 or where R1 is H, vinyl, alkyl or R; and B is a basic N-containing radical. In examples, these compounds (Z=CO) are prepared by reacting RCO 2 Me with the correponding 2-unsubstituted benzoxazinones or -benzothiazinones, or the 3 ...

The synthesis of N-alkylphenoxazinones from orcinol and a primary amine

N-alkylphenoxazinones 4 may be synthesised from orcinol monohydrate (5-Methylbenzene-1,3-diol) and an alkylamine by reaction in aqueous solution at ambient temperature over prolonged times (e.g. several days). Thus, orcinol and methylamine may react to give N-Methyl 3,6-di(1',3'-dihydroxy-5'-methyl-6'-)-4,5-dimethylphenoxazin-2- one-7-oxide (possibly as a mixture of stereoisomers). Reaction with higher member amines may require the use of aqueous hydroxylic solvents. Compound 1 may be produced from orcinol via autooxidation; intermediates 2 and 3 may be formed on reaction with alkylamine. Compound 4 has been characterised via reaction to derivative 5. Compounds 4 may be coloured.

Alkoxylated humus material compositions and methods of making same

Manufacture of new imidazolines

Phenthiazinyl - methyl - imidazolines of the formula and substitution derivatives thereof are prepared by reacting (1) a phenthiazine or N-metal derivative thereof with a reactive ester of a 2-oxymethyl-imidazoline, or (2) a phenthiazine-N-acetic acid with the appropriate alkylene diamine. The benzene nuclei may be substituted by alkyl (e.g. methyl, ethyl), hydroxy, etherified or esterified hydroxy (e.g. methoxy, ethoxy, propyloxy, butyloxy, benzyloxy, acetoxy or benzoyloxy), amino or nitro groups or by halogen atoms. The imidazoline nucleus may contain alkyl substituents, e.g. methyl, ethyl or propyl. In method (1), a halide or alkyl or aryl sulphonate ester of the imidazoline (preferably as salt) may be reacted with the phenthiazine, or N-sodium derivative if no free hydroxy group is present. A diluent and/or condensing agent may or may not be present. For method (2), the reactive derivative may be an imido-ether, imido-halide, thioamide, thio - imido - ether, ...

The Synthesis of,N-alkylbis(orciny)phenox AZinones;N-alkyl 3,6-D1(1'3'-Dihydroxy-5'-methylbenzene 6')4,5-Dimethylphenoxazin-2-one-7-oxides

Phenoxazine derivatives

Novel 10-methyl-phenoxazines of the general formula wherein R is hydrogen, methyl or ethyl, and alkali metal, alkaline earth metal, ammonium and amine salts thereof are prepared when R is hydrogen by subjecting 3-acetyl-10-methyl-phenoxazine to the Willgerodt reaction or the Kindler modification thereof and hydrolysing the resulting amide or thioamide, and when R is H, methyl or ethyl, by hydrolysing a phenoxazine derivative of the formula wherein represents a radical convertible to a carboxy group by hydrolysis such as a cyano, carbamoyl or lower alkoxycarbonyl group. (10 - Methyl - 3 - phenoxazinyl)thioacetomorpholide is prepared by heating sulphur, morpholine and 3-acetyl-10-methylphenoxazine (obtainable from methyl iodide and 3-acetylphenoxazine). Ethyl 2 - (10 - methyl - 3 - phenoxazinyl)-propionate is obtained by esterifying (10-methyl-3-phenoxazinyl)acetic acid with methanol, treating the resulting corresponding methyl ester with ethyl carbonate ...

NEW PHENOXAZINONDERIVATE AS ENZYME SUBSTRATES AND THEIR USE AS INDICATOR WITH THE PROOF OF MICROORGANISMS WITH PEPTIDASEAKTIVITÄT

FROM PHENOXAZINON DERIVED NEW ONES OF ENZYME SUBSTRATES AND THEIR USE AS DEVELOPERS WITH DETECTION OF MICROORGANISMS WITH PEPTIDASEAKTIVITÄT

L-ARGININ-ISOXICAMAT.

PHENOXAZINANALOGE FOR THE TREATMENT OF AMYLOIDOSE

Procedure for the production of new Thiolcarbamidsäurealkylester and their salts

Procedures for the production of N-aminoalkylsubstituierten aromatic or aromatic-hetero-cyclic tertiary amines

Procedures for the production of N, N' substituted Diaminoäthanverbindungen

Procedures for the production of N, N' substituted Diaminoäthanverbindungen

Procedures for the production of N, N' substituted Diaminoäthanverbindungen

Comounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as Alzheimer's disease, and Parkinson's disease

Monomer, Polymerization Method, and Polymer

A monomer of formula (III): wherein X is a polymerisable group Ar, Ar 1 and Ar 2 each independently represent an optionally substituted aryl or heteroaryl group; R 1 represents H or a substituent; and Z represents a direct bond or a divalent linking atom or group, wherein Ar 1 and Ar 2 are linked by a single bond or a divalent linking group selected from CR 1 R 2 , SiR 1 R 2 , PR 1 , NR 1 , O and S wherein R 1 and R 2 are independently selected from hydrogen; optionally substituted alkyl wherein one or more non-adjacent C atoms may be replaced with O, S, N, C═O and —COO—; alkoxy, aryl, arylalkyl, heteroaryl and heteroarylalkyl. Ar 1 and Ar 2 are preferably linked by an oxygen atom, and Ar 1 and/or Ar 2 may be fused to their respective adjacent Ar groups. Ar 1 and its adjacent Ar group and/or Ar 2 and its adjacent Ar group are optionally fused to form a fluorene unit.

Photoelectric conversion element, production method thereof, photosensor, imaging device and their driving method

To provide a photoelectric conversion element capable of functioning as a photoelectric conversion element when a compound having a specific structure is applied to the photoelectric conversion element, causing the element to exhibit a low dark current, and reducing the range of increase in the dark current even when the element is heat-treated, and an imaging device equipped with such a photoelectric conversion element. A photoelectric conversion element having a photoelectric conversion film which is sandwiched between a transparent electrically conductive film and an electrically conductive film and contains a photoelectric conversion layer and an electron blocking layer, wherein the electron blocking layer contains a compound having, as a substituent, a substituted amino group containing three or more ring structures.

Materials for organic electroluminescent devices

The present invention relates to 4,4′-substituted spirobifluorenes which are suitable, owing to excellent properties, as functional materials in organic electroluminescent devices. In addition, the present invention relates to a process for the preparation of 4,4′-substituted spirobifluorenes and to the use of these compounds in organic electroluminescent devices.

Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes and parkinson's disease

Bis- and tris-dihydroxyaryl compounds and their methylenedioxy analogs and pharmaceutically acceptable esters, their synthesis, pharmaceutical compositions containing them, and their use in the treatment of amyloid diseases, especially Aβ amyloidosis, such as observed in Alzheimer's disease, IAPP amyloidosis, such as observed in type 2 diabetes, and synucleinopathies, such as observed in Parkinson's disease, and the manufacture of medicaments for such treatment.

FLUORINATED RESORUFIN COMPOUNDS AND THEIR APPLICATION

The invention provides novel fluorinated resorufin compounds that are of use in a variety of assay formats. Also provided are methods of using the compounds and kits that include a compound of the invention and instructions detailing the use of the compound in one or more assay formats. 2. The compound according to claim 1 , wherein at least one of R claim 1 , R claim 1 , R claim 1 , and Ris fluorine.3. The compound according to claim 1 , wherein A is OR claim 1 , E is OR claim 1 , E is OR claim 1 , and Ris hydrogen.46.-. (canceled)7. The compound according to claim 1 , wherein Rand Rare fluorine.8. The compound according to claim 1 , wherein Rand Rare each fluorine.9. The compound according to claim 1 , wherein R claim 1 , R claim 1 , Rand Rare each fluorine.10. The compound according to claim 1 , wherein Rand Rare each fluorine and R claim 1 , R claim 1 , Rand Rare hydrogen claim 1 , substituted alkyl claim 1 , unsubstituted alkyl claim 1 , substituted alkoxy claim 1 , unsubstituted alkoxy claim 1 , substituted alkylthio claim 1 , unsubstituted alkylthio claim 1 , substituted aryl claim 1 , unsubstituted aryl claim 1 , substituted heteroaryl claim 1 , or unsubstituted heteroaryl.11. The compound according to claim 1 , wherein Rand Rare each fluorine and R claim 1 , R claim 1 , Rand Rare each hydrogen.12. The compound according to claim 1 , wherein Rand Rare each fluorine and R claim 1 , R claim 1 , Rand Rare hydrogen claim 1 , substituted alkyl claim 1 , unsubstituted alkyl claim 1 , substituted alkoxy claim 1 , unsubstituted alkoxy claim 1 , substituted alkylthio claim 1 , unsubstituted alkylthio claim 1 , substituted aryl claim 1 , unsubstituted aryl claim 1 , substituted heteroaryl claim 1 , or unsubstituted heteroaryl.13. The compound according to claim 1 , wherein Rand Rare each fluorine and R claim 1 , R claim 1 , Rand Rare each hydrogen.1417-. (canceled)18. The compound according to claim 1 , wherein Ris hydrogen claim 1 , substituted alkyl or unsubstituted ...

Mediator For Test Sensor

A method of forming a 3-phenylimino-3H-phenothiazine or a 3-phenylimino-3H-phenoxazine mediator includes providing a first reactant including phenothiazine or phenoxazine, providing a first solvent, providing a second reactant and providing a second solvent. The first reactant, first solvent, second reactant and second solvent are combined to form a reactants solution. Sodium persulfate is added to the reactants solution to couple the first and second reactants resulting in a reaction solution including the 3-phenylimino-3H-phenothiazine or the 3-phenylimino-3H-phenoxazine mediator. 125-. (canceled)26. A 3-phenylimino-3H-phenothiazine mediator or 3-phenylimino-3H-phenoxazine mediator wherein the background current is less than 200 nA after being exposed to a temperature of 50° C. for a duration of two weeks.27. The mediator of wherein the mediator is a 3-phenylimino-3H-phenothiazine mediator.28. The mediator of wherein the mediator is a 3-phenylimino-3H-phenoxazine mediator.29. The mediator of wherein the 3-phenylimino-3H-phenothiazine mediator or 3-phenylimino-3H-phenoxazine mediator is in the form of a salt.30. The mediator of wherein the -phenylimino-3H-phenothiazine mediator or 3-phenylimino-3H-phenoxazine mediator is in the form of a acid.31. A test sensor including a base claim 26 , the base including an enzyme adapted to react with an analyte claim 26 , and a mediator claim 26 , the mediator having a background current being less than 200 nA after being exposed to a temperature of 50° C. for a duration of two weeks.32. The test sensor of further including a neutralizing agent.33. The test sensor of wherein the neutralizing agent is sodium hydroxide.34. The test sensor of wherein the neutralizing agent is sodium bicarbonate.35. The test sensor of further including a buffer.36. The test sensor of wherein the buffer is sodium phosphate.37. The test sensor of wherein the test sensor is an electrochemical test sensor.38. The test sensor of wherein the test sensor ...

TRICYCLIC HETEROAROMATIC COMPOUNDS AS ALPHA-SYNUCLEIN LIGANDS

Derivatives of phenothiazine, phenoxazine, and phenazine compounds and their use as α-synuclein ligands are described. Also described are methods of using these compounds and their radiolabeled analogs for the detection, monitoring, and treatment of synucleinopathies, including Parkinson's disease. 2. (canceled)3. (canceled)4. The compound of wherein R is hydrogen claim 1 , C-Calkyl claim 1 , or C-Cacyl.5. The compound of wherein R is hydrogen claim 4 , methyl claim 4 , or acetyl.6. (canceled)7. The compound of wherein one or more of A claim 1 , A claim 1 , A claim 1 , A claim 1 , A claim 1 , A claim 1 , A claim 1 , or Ais nitrogen.8. The compound of wherein either Aor Ais nitrogen and Ais C—R claim 7 , Ais C—R claim 7 , Ais C—R claim 7 , Ais C—R claim 7 , Ais C—R claim 7 , and Ais C—R.9. The compound of claim 1 , wherein Ais C—R claim 1 , Ais C—R claim 1 , Ais C—R claim 1 , Ais C—R claim 1 , Ais C—R claim 1 , Ais C—R claim 1 , Ais C—R claim 1 , and Ais C—R.10. The compound of wherein R claim 1 , R claim 1 , R claim 1 , R claim 1 , R claim 1 , R claim 1 , R claim 1 , and Rare each independently hydrogen claim 1 , fluoro claim 1 , bromo claim 1 , iodo claim 1 , hydroxy claim 1 , substituted or unsubstituted C-Calkyl claim 1 , substituted or unsubstituted C-Calkoxy claim 1 , cyano claim 1 , nitro claim 1 , amino claim 1 , C-Calkylamino claim 1 , or di-C-Calkylamino.11. The compound of wherein R claim 10 , R claim 10 , R claim 10 , R claim 10 , R claim 10 , R claim 10 , R claim 10 , and Rare each independently hydrogen claim 10 , bromo claim 10 , iodo claim 10 , hydroxy claim 10 , C-Calkyl claim 10 , C-Chaloalkyl claim 10 , substituted or unsubstituted C-Calkoxy claim 10 , cyano claim 10 , nitro claim 10 , amino claim 10 , C-Calkylamino claim 10 , or di-C-Calkylamino.12. (canceled)13. The compound of wherein R claim 11 , R claim 11 , R claim 11 , R claim 11 , R claim 11 , R claim 11 , R claim 11 , and Rare each independently hydrogen claim 11 , bromo claim 11 , iodo ...

Lisofylline analogs and methods for use

The present invention provides analogs of a Lysofylline (LSF), and synthetic methods for the preparation of such analogs. The have the active side chain moiety (5-R-hydroxyhexyl) of LSF and can have greater potency and oral bioavailability than LSF.

Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease

Bis- and tris-dihydroxyaryl compounds and their methylenedioxy analogs and pharmaceutically acceptable esters, their synthesis, pharmaceutical compositions containing them, and their use in the treatment of amyloid diseases, especially Aβ amyloidosis, such as observed in Alzheimer's disease, IAPP amyloidosis, such as observed in type 2 diabetes, and synucleinopathies, such as observed in Parkinson's disease, and the manufacture of medicaments for such treatment.

MATERIALS FOR ELECTRONIC DEVICES

The present invention relates to compounds according to formula (I), which are suitable for use in electronic devices, preferably organic electroluminescent devices. 118-. (canceled)20. The compound of claim 19 , wherein the compound of formula claim 19 , (1) contains exactly one Y wherein a group of formula (N) is bonded thereto instead of R.21. The compound of claim 19 , wherein in the group of formula (N) claim 19 , Aris the same or different in each instance and is selected from the group consisting of phenyl claim 19 , naphthyl claim 19 , phenanthrenyl claim 19 , biphenyl claim 19 , terphenyl claim 19 , quaterphenyl claim 19 , fluorenyl claim 19 , indenofluorenyl claim 19 , carbazolyl claim 19 , dibenzothiophenyl claim 19 , dibenzofusanyl claim 19 , benzofuranyl claim 19 , benzothiophenyl claim 19 , indolyl claim 19 , triazinyl claim 19 , pyrimidinyl claim 19 , pyridyl claim 19 , and pyridazinyl claim 19 , each of which is optionally substituted by one or more radicals R.22. The compound of claim 19 , wherein Aris the same in each instance.25. The compound of claim 19 , wherein all Y are CR.26. The compound of claim 19 , wherein X is C(R).27. The compound of claim 19 , wherein the radicals Rof X are the same or different in each instance and are selected from the group consisting of straight-chain alkyl groups having 1 to 12 carbon atoms claim 19 , branched or cyclic alkyl groups having 3 to 12 carbon atoms claim 19 , and aromatic ring systems having 6 to 20 aromatic ring atoms; wherein the alkyl groups and aromatic ring systems are each optionally substituted by one of more radicals R.28. The compound of claim 19 , Therein the radicals Rin Y are the same or different each instance and are selected from the group consisting of H claim 19 , D claim 19 , F claim 19 , CN claim 19 , straight-chain alkyl groups having 1 to 20 carbon atoms claim 19 , branched or cyclic alkyl groups having 3 to 20 carbon atoms claim 19 , aromatic ring systems having 6 to 40 aromatic ...

SPIRO-TYPE COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME

The present specification provides a compound having a spiro structure, and an organic light emitting device including the same. 3. The compound of claim 1 , wherein HAr is a substituted or unsubstituted pyridyl group; a substituted or unsubstituted pyrimidyl group; a substituted or unsubstituted triazinyl group; a substituted or unsubstituted furan group; a substituted or unsubstituted thiophene group; a substituted or unsubstituted oxadiazole group; a substituted or unsubstituted thiadiazole group; a substituted or unsubstituted phenanthroline group; a substituted or unsubstituted quinolinyl group; a substituted or unsubstituted isoquinolinyl group; a substituted or unsubstituted quinazoline group; a substituted or unsubstituted benzoxazole group; a substituted or unsubstituted benzothiazole group; a substituted or unsubstituted benzimidazole group; a substituted or unsubstituted phenoxazine group; a substituted or unsubstituted phenothiazine group; a substituted or unsubstituted dibenzofuran group; a substituted or unsubstituted dibenzothiophene group; a substituted or unsubstituted carbazole group; or a substituted or unsubstituted diarylphosphine oxide group.7. An organic light emitting device comprising:a first electrode;a second electrode provided opposite to the first electrode; andone or more organic material layers provided between the first electrode and the second electrode,{'claim-ref': {'@idref': 'CLM-00001', 'claim 1'}, 'wherein one or more layers of the organic material layers include the compound of .'}8. The organic light emitting device of claim 7 , wherein the organic material layer includes a light emitting layer claim 7 , and the light emitting layer includes the compound.9. The organic light emitting device of claim 8 , wherein the light emitting layer further includes a light emitting dopant.10. The organic light emitting device of claim 7 , wherein the organic material layer includes an electron injection layer claim 7 , an electron transfer ...

Organic functional compound for preparing organic electronic device and application thereof

The present invention discloses an organic functional compound for preparing an organic electronic device and an application thereof. The organic functional compound has a general formula (I). The organic functional compound comprises an organic functional group and a solubilizing group, thereby imparting a good solubility and film-forming ability. The organic functional compound also excels in maintaining the performance of the functional group in a device. The organic functional compound and a composition or mixture comprising the organic functional compound have a good printability and film-forming ability, facilitating solution-processing, particularly in printing techniques, and obtaining a high-performance small-molecule organic electronic device, particularly an organic electroluminescent device. FSG] k   (I)

SPIROBIFLUORENE COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT DEVICES

The present invention relates to compounds of the formula (1) which are suitable for use in electronic devices, in particular organic electroluminescent devices, and to electronic devices which comprise these compounds. 115-. (canceled)17. The compound according to claim 16 , wherein i is 0.22. The compound according to claim 21 , wherein Arand Arare selected claim 21 , identically or differently on each occurrence claim 21 , from the groups of the formulae (11) claim 21 , (20) and (24) claim 21 , which may be substituted by one or more radicals R.23. The compound according to claim 16 , wherein the groups Arand Arare selected differently from one another.24. The compound according to claims 16 , wherein Rto Rare selected claims 16 , identically or differently on each occurrence claims 16 , from the group consisting of H claims 16 , F claims 16 , CN claims 16 , a straight-chain alkyl or alkoxy group having 1 to 10 C atoms or a branched or cyclic alkyl or alkoxy group having 3 to 10 C atoms claims 16 , each of which may be substituted by one or more radicals R claims 16 , where one or more non-adjacent CHgroups may be replaced by O and where one or more H atoms may be replaced by F claims 16 , an aromatic or heteroaromatic ring system having 6 to 24 aromatic ring atoms claims 16 , which may in each case be substituted by one or more radicals R.25. The compound according to claim 16 , wherein the radical Rwhich is bonded to Aror Aror Aris selected claim 16 , identically or differently on each occurrence claim 16 , from the group consisting of H claim 16 , F claim 16 , CN claim 16 , a straight-chain alkyl group having 1 to 10 C atoms claim 16 , a branched or cyclic alkyl group having 3 to 10 C atoms or an aromatic or heteroaromatic ring system having 5 to 24 aromatic ring atoms claim 16 , each of which may be substituted by one or more radicals R.26. The compound according to claim 16 , wherein Arand Arare not connected to one another by a group E.27. The compound ...

SELECTIVE DETECTION OF THIOLS

Probes for selectively detecting compounds comprising a thiol group and an amino group (“thiols”) are disclosed. Exemplary thiols include cysteine, homocysteine, and glutathione. Embodiments of the disclosed probes produce a detectable change in absorbance spectrum and/or emission spectrum when reacted with one or more thiols in solution. Methods and kits for performing the detection also are disclosed. The probes have a general formula 23-. (canceled)4. The compound of where Xis O or S claim 1 , and Rand R-Rindependently are H or lower alkyl.56-. (canceled)7. The compound of where Xis O claim 1 , Rand Rtogether form an aryl ring claim 1 , Xis N or CR claim 1 , Ris lower alkyl or H claim 1 , Ris an acrylate ester claim 1 , and R-Rare H.813-. (canceled)16. The compound of where each of Rand Ris an acrylate ester claim 15 , and Ris —COOH or Ris —C(O)O— and forms a ring system with rings B and E.17. (canceled)18. The compound of where R claim 16 , R-R claim 16 , Rand R-Rindependently are H or lower alkyl.19. (canceled)20. The compound of where Xis O.22. A method for selectively detecting a compound comprising a thiol group and an amino group claim 18 , comprising:{'claim-ref': {'@idref': 'CLM-00001', 'claim 1'}, 'combining a sample potentially comprising at least one compound comprising a thiol group and an amino group with a solution comprising a probe having a structure according to to produce a reaction mixture;'}allowing a reaction between the sample and the probe to proceed for an effective period of time to produce a detectable change in the reaction mixture's absorbance spectrum, emission spectrum, or both, where the change indicates that the compound is present; anddetecting the change.2325-. (canceled)26. The method of where the sample comprises blood claim 22 , a blood product claim 22 , a blood component claim 22 , urine claim 22 , a urine product claim 22 , or a urine component.27. The method of claim 26 , further comprising:obtaining plasma;reducing the ...

REDUNDANT POWER LINE CONTROL SYSTEMS

Methods, systems, and apparatus for monitoring and controlling electronic devices using wired and wireless protocols are disclosed. The systems and apparatus may monitor their environment for signals from electronic devices. The systems and apparatus may take and disambiguate the signals that are received from the devices in their environment to identify the devices and associate control signals with the devices. The systems and apparatus may use communication means to send control signals to the identified electronic devices. Multiple apparatuses or systems may be connected together into networks, including mesh networks, to make for a more robust architecture. 1. A system for controlling electronic devices located at a site , comprising: a processor; and', 'a memory coupled to the processor;', 'wherein the control apparatus is configured to couple to at least one conductor in a power line associated with an electronic device receiving power from the power line, and wherein the control apparatus is configured to redirect electrical power from the at least one conductor through the control apparatus and to the electronic device;, 'a plurality of control apparatus, wherein one or more of the control apparatus comprisewherein a first control apparatus and a second control apparatus are configured to establish a communication link to at least one electronic device located at the site, the communication link comprising at least one of a wireless communication link and a power line communication link; andwherein at least one of the first control apparatus and the second control apparatus is configured to monitor and control the at least one electronic device using the established communication link.2. The apparatus of claim 1 , wherein at least one of the first control apparatus and the second control apparatus are configured to establish a wireless communication link with a remote device.3. The apparatus of claim 2 , wherein the control apparatus having the wireless ...

SULFONAMIDES DERIVED FROM TRICYCLYL-2-AMINOCYCLOALKANOLS AS ANTICANCER AGENTS

A genus of arylsulfonamide derivatives of aminocycloalkanols is disclosed. The compounds are of the following genus: 4. A compound according to wherein n is one.5. A compound according to wherein n is zero.6. (canceled)7. A compound according to claim 1 , wherein B is a direct bond.8. A compound according to claim 1 , wherein B is —O—.9. A compound according to claim 1 , wherein B is —(CH—O)— or —(O—CH)—.10. A compound according to claim 1 , wherein B is —C(═O)N(CH)— or —N(CH)C(═O)—.11. A compound according to claim 1 , wherein A is N.1215-. (canceled)16. A compound according to claim 1 , wherein A is —CH.17. A compound according to claim 1 , wherein T and U are both benzene rings.18. A compound according to claim 1 , wherein one of T and U is a benzene ring claim 1 , and the other of T and U is selected from pyridine claim 1 , pyrimidine claim 1 , and thiophene.19. A compound according to claim 1 , wherein Rand Rare H claim 1 , and Rand Rare chosen independently from H claim 1 , OH claim 1 , F claim 1 , Cl claim 1 , Br claim 1 , CN claim 1 , COCH claim 1 , CH claim 1 , CF claim 1 , OCF claim 1 , and OCH.20. (canceled)21. (canceled)22. A compound according to claim 1 , wherein Ris H claim 1 , and Ris chosen from H claim 1 , F claim 1 , Cl claim 1 , CF claim 1 , OCF claim 1 , SCF claim 1 , Nand CN.2325-. (canceled)26. A compound according to wherein Ris in the para position.2730-. (canceled)3241-. (canceled)42. A method for restoring sensitivity to one or more chemotherapeutic agents in the treatment of cancer claim 1 , the method comprising administering an effective amount of a compound according to .43. A method for treating a disease or disorder in a patient where the disease or disorder involves the dysregulation of the PI3K-AKT-FOXO signaling pathway claim 1 , the method comprising administering to the patient a therapeutically effective amount of a compound according to .44. A pharmaceutical composition comprising a pharmaceutically acceptable carrier and a ...

BLUE FLUORESCENT EMITTERS

The present invention relates to compounds of the formula (I) 8. Use of at least one compound according to in an optoelectronic component from the group comprising: an organic electroluminescent device (OLED) claim 1 , an organic integrated circuit (O-IC) claim 1 , an organic field-effect transistor (O-FET) claim 1 , an organic thin-film transistor (O-TFT) claim 1 , an organic light-emitting transistor (O-LET) claim 1 , an organic solar cell (O-SC) claim 1 , an organic optical detector claim 1 , an organic photoreceptor claim 1 , an organic field-quench device (O-FQD) claim 1 , a light-emitting electrochemical cell (LEC) claim 1 , or an organic laser diode (O-laser).9. An optoelectronic component comprising at least one compound according to . The present application is a national stage entry according to 35 U.S.C. §371 of PCT Application No. PCT/EP2016/052413 filed on Feb. 4, 2016, which claims priority to German Patent Application No. 10 2015 101 767.9, filed on Feb. 6, 2015; both of which are herein incorporated by reference in their entirety.The subject matter herein generally provides compounds of formula (I) as defined herein, as well as their use as emitter or carrier material in an optoelectronic component.The development of novel functional compounds for use in electronic devices is currently the subject of intensive research. The aim here is the development and study of compounds which have not been used to date in electronic devices, and the development of compounds which enable an improved profile of properties of the devices.According to a non-limiting embodiment, the term “optoelectronic component” is understood to mean inter alia organic integrated circuits (OICs), organic field-effect transistors (OFETs), organic thin-film transistors (OTFTs), organic light-emitting transistors (OLETs), organic solar cells (OSCs), organic optical detectors, organic photoreceptors, organic field-quench devices (OFQDs), organic light-emitting electrochemical cells ( ...

ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES

A compound having a structure of Formula I, 2. The compound of claim 1 , wherein at least one R comprises at least one donor group selected from the group consisting of carbazole claim 1 , diphenylamino claim 1 , phenoxazine claim 1 , phenothiazine claim 1 , dibenzoazasiline claim 1 , pyrrolidine claim 1 , piperidine claim 1 , phenoxide claim 1 , and methoxide.3. The compound of claim 1 , wherein at least one R comprises at least one acceptor group selected from the group consisting of cyano claim 1 , pyrazole claim 1 , imidazole claim 1 , triazole claim 1 , pyridine claim 1 , pyrimidine claim 1 , triazine claim 1 , aza-carbazole claim 1 , aza-dibenzofuran claim 1 , and aza-dibenzothiophene group.4. The compound of claim 1 , wherein each one of Zthrough Zis CR.5. The compound of claim 1 , wherein at least one of Zthrough Zis N.7. The compound of claim 1 , wherein at least two Rs comprise donor substituents claim 1 , and one R comprises an acceptor substituent; or at least two Rs comprise acceptor substituents claim 1 , and one R comprises a donor substituent.10. The OLED of claim 9 , wherein the organic layer is an emissive layer and the compound is a host.11. The OLED of claim 9 , wherein the organic layer is a blocking layer and the compound is a blocking material in the organic layer claim 9 , or organic layer is a transporting layer and the compound is a transporting material in the organic layer.12. The OLED of claim 9 , wherein the organic layer is an emissive layer and the compound is an emitter.13. The OLED of claim 12 , wherein the OLED emits a luminescent radiation at room temperature when a voltage is applied across the first organic light emitting device; wherein the luminescent radiation comprises a delayed fluorescent process.14. The OLED of claim 13 , wherein the organic layer further comprises a sensitizer; andwherein the sensitizer is a phosphorescent emitting material.15. The OLED of claim 9 , wherein the organic layer further comprises a ...

CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME

A condensed cyclic compound is represented by Formula 1 below:

Materials for organic electroluminescent devices

The present invention relates to compounds of the formula (1) which are suitable for use in electronic devices, in particular organic electroluminescent devices, and to electronic devices which comprise these compounds.

APPARATUS FOR COUPLING TO EXISTING POWER LINES

Methods, systems, and apparatus for monitoring and controlling electronic devices using wired and wireless protocols are disclosed. The systems and apparatus may monitor their environment for signals from electronic devices. The systems and apparatus may take and disambiguate the signals that are received from the devices in their environment to identify the devices and associate control signals with the devices. The systems and apparatus may use communication means to send control signals to the identified electronic devices. Multiple apparatuses or systems may be connected together into networks, including mesh networks, to make for a more robust architecture. 1. A clamp , comprising:a non-conductive blade;a conductive blade, wherein the conductive blade is offset from the non-conductive blade;wherein the non-conductive blade is configured to sever a power line and disrupt power through the power line;wherein the conductive blade is configured to splice into the power line and redirect the power from the power line while also providing the power back to the power line.2. The clamp of claim 1 , wherein the conductive blade is configured to splice into the power line simultaneously with the non-conductive blade.3. The clamp of claim 1 , further comprising an insulated tube claim 1 , wherein a portion of the non-conductive blade and a portion of the conductive blade are positioned in the insulated tube.4. The clamp of claim 3 , further comprising a contact pad claim 3 , wherein a first portion of the contact pad is electrically connected to the conductive blade claim 3 , and wherein a second portion of the contact pad is electrically connected to an electronic device control apparatus.5. The clamp of claim 4 , wherein the contact pad facilitates flow of current from inside of the insulated tube to an area outside of the insulated tube.6. The clamp of claim 1 , wherein the non-conductive blade comprises a piercing surface configured to splice into the power line.7. ...

Method and apparatus for performing an energy audit

Methods and apparatuses for performing an energy audit are disclosed, including using one or more current sensors clamped to an existing lighting system to measure one or more current or voltage signals over a first period of time; calculating a first power usage from the one or more current or voltage signals; replacing the existing lighting system with a replacement lighting system; using the one or more current sensors to measure one or more current or voltage signals of the replacement lighting system over a second period of time; calculating a second power usage from the one or more current or voltage signals; determining a power difference between the first power usage and the second power usage; using the power difference to estimate a cost savings between the first period of time and the second period of time; and generating an energy audit report. Other embodiments are described and claimed.

ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES

The invention relates to an organic molecule having precisely two units of formula I linked to one another via a single bond or a bridge Y 119-. (canceled)21. The organic molecule according to claim 20 , wherein{'sup': 4', '4', '4', '4, 'sub': '2', 'R′=the attachment position for the second unit of the formula I or selected from the group consisting of Y, H, N(R), OR, a linear alkyl or alkoxy group having 1 to 40 carbon atoms or a branched or cyclic alkyl or alkoxy group having 3 to 40 carbon atoms wherein this group is optionally substituted in each case by one or more radicals R, and an aromatic or heteroaromatic ring system having 5 to 60 aromatic ring atoms wherein this ring system is optionally substituted in each case by one or more radicals R; and'}{'sup': 4', '4', '4', '4, 'sub': '2', 'R″=the attachment position for the second unit of the formula I or selected from the group consisting of Y, N(R), OR, a linear alkyl or alkoxy group having 1 to 40 carbon atoms or a branched or cyclic alkyl or alkoxy group having 3 to 40 carbon atoms wherein this group is optionally to be substituted in each case by one or more radicals R, and an aromatic or heteroaromatic ring system having 5 to 60 aromatic ring atoms wherein this ring system is optionally substituted in each case by one or more radicals R;'}wherein the heteroaromatic ring system is not an N-heteroaromatic;wherein, if R′ is Y, R″ is not Y, and, if R″ is Y, R′ is not Y;wherein if R′ is the attachment position for the second unit of the formula I, then R″ is not the attachment position for the second unit of the formula I, and, if R″ is the attachment position for the second unit of the formula I, then R′ is not the attachment position for the second unit of the formula I; and{'sup': '4', 'wherein Y and Rhave the aforestated meanings.'}22. The organic molecule according to claim 20 , wherein{'sup': 4', '4', '4', '4', '4, 'sub': '2', 'R′=the attachment position for the second unit of the formula I or selected ...

LIGHT EMITTING DEVICES AND COMPOUNDS

Thermally Activated Delayed Fluorescence (TADF) compounds wherein two aromatic heterocyclic moieties are provided as acceptor groups, spaced apart from two donor moieties by an aromatic spacer ring, are described. Charged organic TADF species having a similar structure are also described. The TADF compounds and charged organic TADF species may be employed as emitter material in light emitting devices such as OLEDs and LEECs. Also described TADF compounds wherein at least one donor moiety is substituted by at least one substituent that is a phosphine oxide or a phosphine sulphide. 137-. (canceled)44. A light emitting device comprising a TADF compound according to .45. The light emitting device of claim 44 , wherein said light emitting device is an OLED.492. The TADF compound according to claim 46 , wherein the acceptor moieties Acc are claim 46 , independently for each occurrence selected from the group consisting of -Het as defined in claim claim 46 , —CN claim 46 , sulfone claim 46 , sulfoxide claim 46 , imine claim 46 , amide claim 46 , acridine claim 46 , acridinium claim 46 , carboxylate ester claim 46 , phosphine oxide claim 46 , phosphine sulfide claim 46 , ketone and aldehyde.52. A light emitting device comprising a TADF compound according to .53. The light emitting device of claim 52 , wherein said light emitting device is an OLED.57. The charged organic species according to claim 56 , wherein at least one linking group L is present and is independently for each occurrence claim 56 , a hydrocarbylene chain claim 56 , that may be substituted or unsubstituted claim 56 , hydrocarbylene or unsaturated hydrocarbylene.58. The charged organic species according to claim 57 , wherein the at least one linking group L is selected from substituted or unsubstituted cyclopentane-1 claim 57 ,3-diyl claim 57 , cyclohexane-1 claim 57 ,4-diyl claim 57 , 1 claim 57 ,4-phenylene and 4 claim 57 ,4′-biphenylene.60. The charged organic species according to claim 56 , wherein ...

Piperazine derivatives, pharmaceutical compositions and methods of use thereof

The present invention relates to novel piperazine derivatives, methods for their preparation, pharmaceutical compositions including such compounds, and methods of using these compounds and compositions, especially for targeted therapy treatment of hyperproliferative disorders, including benign hyperproliferative disorders, cancer and pre-cancer conditions.

RESORUFIN DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISORDERS

Disclosed herein are resorufin derivative compounds and methods of using such compounds for treating or suppressing oxidative stress disorders, including mitochondrial disorders, impaired energy processing disorders, neurodegenerative diseases and diseases of aging. 2. The compound of claim 1 , wherein R claim 1 , R claim 1 , and Rare —CH.3. The compound of claim 1 , wherein Rand Rare —OCH claim 1 , and Ris —CH.4. The compound of claim 1 , wherein Rand Rare —CH claim 1 , and Ris —H.5. The compound of claim 1 , wherein Rand Rare —CH claim 1 , and wherein Ris -n-C-Calkyl.6. The compound of claim 1 , wherein Rand Rare —OCH claim 1 , and wherein Ris -n-C-Calkyl.9. The compound of claim 1 , wherein R claim 1 , R claim 1 , and Rare —H.10. The compound of claim 1 , wherein three of R claim 1 , R claim 1 , R claim 1 , and Rare —H.1110. The compound of any one of - claims 1 , wherein at least one of R claims 1 , R claims 1 , R claims 1 , and Ris —C-Chaloalkyl.1210. The compound of any one of - claims 1 , wherein at least one of R claims 1 , R claims 1 , R claims 1 , and Ris —C(O)—N(R)(R).1310. The compound of any one of - claims 1 , wherein at least one of R claims 1 , R claims 1 , R claims 1 , and Ris —C-Calkyl.149. The compound of any one of - claims 1 , wherein R claims 1 , R claims 1 , R claims 1 , and Rare —H.2221. A pharmaceutical formulation comprising a compound according to any one of - and a pharmaceutically acceptable excipient.24. The method of claim 23 , wherein the method is a method of treating an oxidative stress disorder selected from the group consisting of: a mitochondrial disorder; an inherited mitochondrial disease; Alpers Disease; Barth syndrome; a Beta-oxidation Defect; Carnitine-Acyl-Carnitine Deficiency; Carnitine Deficiency; a Creatine Deficiency Syndrome; Co-Enzyme Q10 Deficiency; Complex I Deficiency; Complex II Deficiency; Complex III Deficiency; Complex IV Deficiency; Complex V Deficiency; COX Deficiency; chronic progressive external ...

FLUORINATED RESORUFIN COMPOUNDS AND THEIR APPLICATION

The invention provides novel fluorinated resorufin compounds that are of use in a variety of assay formats. Also provided are methods of using the compounds and kits that include a compound of the invention and instructions detailing the use of the compound in one or more assay formats. 2. The compound according to claim 1 , wherein Rand Rare each fluorine and R claim 1 , R claim 1 , Rand Rare hydrogen claim 1 , substituted alkyl claim 1 , unsubstituted alkyl claim 1 , substituted alkoxy claim 1 , unsubstituted alkoxy claim 1 , substituted alkylthio claim 1 , unsubstituted alkylthio claim 1 , substituted aryl claim 1 , unsubstituted aryl claim 1 , substituted heteroaryl claim 1 , or unsubstituted heteroaryl.3. The compound of claim 2 , wherein R claim 2 , R claim 2 , Rand Rare hydrogen.4. The compound of claim 1 , wherein Rand Rare each fluorine and R claim 1 , R claim 1 , Rand Rare hydrogen claim 1 , substituted alkyl claim 1 , unsubstituted alkyl claim 1 , substituted alkoxy claim 1 , unsubstituted alkoxy claim 1 , substituted alkylthio claim 1 , unsubstituted alkylthio claim 1 , substituted aryl claim 1 , unsubstituted aryl claim 1 , substituted heteroaryl claim 1 , or unsubstituted heteroaryl.5. The compound of claim 4 , wherein R claim 4 , R claim 4 , Rand Rare hydrogen.6. The compound of claim 1 , wherein R claim 1 , R claim 1 , Rand Rare each fluorine and Rand Rare hydrogen claim 1 , substituted alkyl claim 1 , unsubstituted alkyl claim 1 , substituted alkoxy claim 1 , unsubstituted alkoxy claim 1 , substituted alkylthio claim 1 , unsubstituted alkylthio claim 1 , substituted aryl claim 1 , unsubstituted aryl claim 1 , substituted heteroaryl claim 1 , or unsubstituted heteroaryl.9. The compound according to claim 8 , wherein{'sup': 3', '6', '2', '4', '5', '7, '(i) Rand Rare each fluorine and R, R, Rand Rare hydrogen, substituted alkyl, unsubstituted alkyl, substituted alkoxy, unsubstituted alkoxy, substituted alkylthio, unsubstituted alkylthio, substituted ...

ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY DEVICE, LIGHTING DEVICE, PI-CONJUGATED COMPOUND, AND LIGHT-EMITTING THIN FILM

An object of the present invention is to provide an organic electroluminescent element containing an organic layer interposed between an anode and a cathode, the organic layer containing at least one light emitting layer, wherein the at least one light emitting layer contains a π-conjugated compound having an electron donor portion and an electron acceptor portion in the molecule; the π-conjugated compound has a direction vector from an atom having a HOMO orbital in the electron donor portion to an electron cloud of the HOMO orbital, and a direction vector from an atom having a LUMO orbital in the electron acceptor portion to an electron cloud of the LUMO orbital, and the two direction vectors form an angle θ in the range of 90 to 180 degrees; and the π-conjugated compound has a plurality of the electron donor portions or a plurality of the electron acceptor portions. 2. The organic electroluminescent element described in claim 1 ,wherein the angle θ is in the range of 135 to 180 degrees.3. The organic electroluminescent element described in claim 1 ,wherein one of the electron acceptor portions is bonded to two or more electron donor portions through the linking group, or one of the electron donor portions is bonded to two or more electron acceptor portions through the linking group.4. The organic electroluminescent element described in claim 1 ,wherein one of the electron acceptor portions is directly bonded to two or more electron donor portions, or one of the electron donor portions is directly bonded to two or more electron acceptor portions.5. The organic electroluminescent element described in claim 1 ,{'sup': 1', '2', '4', '5', '7', '8', '1', '7', '10', '16', '19', '20, 'wherein the electron donor portion and the electron acceptor portion represented by X, X, X, X, X, X, Yto Y, Yto Y, Y, and Yin Formulas (1), (2), (4), (5), (7), and (8) each respectively are one selected from the group consisting of an aryl group which may have a substituent, a heteroaryl ...

Nitrogen-containing compound, electronic element and electronic device

The present disclosure provides a nitrogen-containing compound, an electronic element and an electronic device, which belongs to the technical field of organic materials. The nitrogen-containing compound has a structure of Chemical Formula 1, wherein R1 and R2 are each independently selected from hydrogen or a group represented by Chemical Formula 1-1, and one and only one of R1 and R2 has the group of Chemical Formula 1-1; when R1 or R2 is selected from hydrogen, said R1 and R2 may be replaced by R4. The nitrogen-containing compound can improve the performance of electronic elements.

COMPOUND CONTAINING BASIC DYE AND AMINO ACID, HAIR DYING DYE, AND HAIR DYING COMPOSITION

There is provided a compound represented by the following general formula (1). 1. A compound represented by the following general formula (1).{'br': None, '[Chem. 1]'}{'br': None, '(X)(Z) \u2003\u2003(1)'}(wherein, X represents a basic dye having at least one amino group having 0 to 20 carbon atoms which may have a substituent, andZ represents a non-coloring anion including an amino acid.)6. The compound according to claim 1 , whereinthe non-coloring anion including an amino acid represented by Z in the general formula (1) is an amino acid anionic surfactant.7. A hair dyeing dye including the compound according to .8. A hair dyeing composition claim 1 , comprising:{'claim-ref': {'@idref': 'CLM-00007', 'claim 7'}, 'the hair dyeing dye according to ;'}an auxiliary selected from the group consisting of a wetting agent, a swelling agent, a penetrating agent, a solvent, a pH adjusting agent, a surfactant, a fragrance, and a thickener; andwater.9. The compound according to claim 2 , whereinthe non-coloring anion including an amino acid represented by Z in the general formula (1) is an amino acid anionic surfactant.10. The compound according to claim 3 , whereinthe non-coloring anion including an amino acid represented by Z in the general formula (1) is an amino acid anionic surfactant.11. The compound according to claim 4 , whereinthe non-coloring anion including an amino acid represented by Z in the general formula (1) is an amino acid anionic surfactant.12. The compound according to claim 5 , whereinthe non-coloring anion including an amino acid represented by Z in the general formula (1) is an amino acid anionic surfactant. This application claims priority to Japanese Application No. 2018-162579, filed Aug. 31, 2018; which is hereby incorporated by reference in its entirety.The present disclosure relates to a compound including a basic dye and an amino acid, a hair dyeing dye, and a hair dyeing composition. More specifically, the present disclosure relates to a hair ...

Thermally activated delayed fluorescence material and application thereof in organic electroluminescence device

and X is bromine or iodine. The present invention further discloses application of the thermally activated delayed fluorescence material as a host material or a luminescent dye of a luminescent layer of an organic electroluminescence device.

ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES

Compounds that are organic radicals that can have a dual function. The compounds can be fluorescent emitters that emit in the near-IR. The compounds can also facilitate reverse intersystem crossing (RISC) to convert triplet excitons in an OLED to singlet excited states to maximize utilization of generated excitons in the OLED and approach 100% internal quantum efficiency. 2. The compound of claim 1 , wherein each Rto R claim 1 , and each R claim 1 , R claim 1 , R claim 1 , R claim 1 , and Rare independently selected from the group consisting of hydrogen claim 1 , deuterium claim 1 , fluorine claim 1 , chlorine claim 1 , nitrile claim 1 , alkyl claim 1 , cycloalkyl claim 1 , alkoxy claim 1 , aryloxy claim 1 , amino claim 1 , silyl claim 1 , aryl claim 1 , heteroaryl claim 1 , and combinations thereof.6. The compound of claim 3 , wherein the compound has a peak emission wavelength λin a range from 700 nm to 1000 nm.8. The OLED of claim 7 , wherein the organic layer further comprises fluorescent emitter.10. The OLED of claim 7 , wherein the organic layer further comprises a host claim 7 , wherein the host comprises at least one chemical group selected from the group consisting of triphenylene claim 7 , carbazole claim 7 , dibenzothiophene claim 7 , dibenzofuran claim 7 , dibenzoselenophene claim 7 , azatriphenylene claim 7 , azacarbazole claim 7 , aza-dibenzothiophene claim 7 , aza-dibenzofuran claim 7 , and aza-dibenzoselenophene.12. A consumer product comprising the device of claim 7 , wherein the consumer product is selected from the group consisting of a flat panel display claim 7 , a curved display claim 7 , a computer monitor claim 7 , a medical monitor claim 7 , a television claim 7 , a billboard claim 7 , a light for interior or exterior illumination and/or signaling claim 7 , a heads-up display claim 7 , a fully or partially transparent display claim 7 , a flexible display claim 7 , a rollable display claim 7 , a foldable display claim 7 , a stretchable ...

3,6-DISUBSTITUTED XANTHYLIUM SALTS

Described are a compound of formula (II) or (III): 2. A method according to claim 1 , wherein X is selected from the group consisting of: NO claim 1 , ClO claim 1 , F claim 1 , Cl claim 1 , Br claim 1 , I claim 1 , ZnCl claim 1 , FeCl and PF.3. A method according to claim 1 , wherein —Ris independently —H claim 1 , or saturated aliphatic Calkyl claim 1 , which is unsubstituted or substituted with —R.4. A method according to claim 1 , wherein —Ris saturated aliphatic Calkyl claim 1 , which is unsubstituted or substituted with one or more substituents —R.5. A method according to claim 4 , wherein each —Ris independently selected from —F claim 4 , —Cl claim 4 , —Br claim 4 , or —I.6. A method according to claim 4 , wherein —Ris —CF.7. A method according to claim 1 , wherein —Ris phenyl claim 1 , which is substituted with one or more substituents —R.8. A method according to claim 7 , wherein each —Ris independently selected from NHand NO.9. A method according to claim 4 , wherein —Ris -Et.10. A method according to claim 1 , wherein the compound is a compound of formula (II) wherein —R claim 1 , —R claim 1 , —Rand —Rare each independently saturated aliphatic Calkyl.11. A method according to claim 10 , wherein —Rand —Rare each independently selected from: —H claim 10 , saturated Calkyl claim 10 , Calkenyl claim 10 , and halogenated Calkyl.13. A method according to claim 12 , wherein one of —Rand —R claim 12 , and one of —Rand —Ris -Et.14. A method according to claim 12 , wherein —R claim 12 , —R claim 12 , —Rand —Rare each -Et.15. A method according to claim 12 , wherein Rand R claim 12 , together with the nitrogen atom to which they are bound claim 12 , form a saturated Cheterocycle and Rand R claim 12 , together with the nitrogen atom to which they are bound claim 12 , independently form a saturated Cheterocycle{'sub': '3-7', 'wherein each of said saturated Cheterocycles is independently selected from: morpholine, piperidine, and pyrrolidine.'}18. A method according to ...

Heterocyclic compound, and organic electroluminescence device and organic electroluminescence display device including the same

Provided are a heterocyclic compound represented by Formula 1 and an organic electroluminescence device and an organic electroluminescence display device including the heterocyclic compound represented by Formula 1 in an emission layer. In Formula 1, A is represented by Formula 2, D 1 is represented by Formula 3, and D 2 is represented by Formula 4.

METHODS AND SYSTEMS FOR WIRELESS TO POWER LINE COMMUNICATION

Methods, systems, and apparatus for monitoring and controlling electronic devices using wired and wireless protocols are disclosed. The systems and apparatus may monitor their environment for signals from electronic devices. The systems and apparatus may take and disambiguate the signals that are received from the devices in their environment to identify the devices and associate control signals with the devices. The systems and apparatus may use communication means to send control signals to the identified electronic devices. Multiple apparatuses or systems may be connected together into networks, including mesh networks, to make for a more robust architecture. 1. A system , comprising:a memory that stores instructions; and connecting a multifunction communication cube to a circuit;', 'recording, by utilizing the multifunction communication cube, signal noise from the circuit;', 'transmitting the signal noise to a remote device;', 'receiving, from the remote device, an identification a device connected to the circuit, wherein the device is identified based on a comparison of the signal noise to a first device waveform; and', 'generating a command signal associated with the device., 'a processor that executes the instructions to perform operations, the operations comprising2. The system of claim 1 , wherein the operations further comprise associating the command signal with the device.3. The system of claim 1 , wherein the operations further comprise facilitating determination of a second device waveform within the signal noise.4. The system of claim 3 , wherein the operations further comprise facilitating the identification of the device by determining that the second device waveform corresponds to the first device waveform.5. The system of claim 1 , wherein the operations further comprise controlling the device by utilizing the command signal.6. The system of claim 1 , wherein the operations further comprise interacting with the device by utilizing the command ...

HUMIC ACID DERIVATIVES AND METHODS OF PREPARATION AND USE

Disclosed are antioxidative natural compounds, their salts, chelates and cleavage derivatives that exhibit a superior combination of properties. The compounds can be used for a variety of purposes, including the stabilization of polymers. The compounds can be prepared by substantially cleaving a humic acid of formula I followed by esterification to provide at least one antioxidant compounds of formula V, formula VI, formula VII, formula VIII, salts thereof, or chelates thereof. 2. The compound of claim 1 , wherein the humic acid derivative of formula VI claim 1 , formula VII claim 1 , formula VIII claim 1 , a salt claim 1 , chelate claim 1 , or combination thereof comprises:{'sub': 2', '1', '20, 'Ris hydrogen or —(C-Calkyl;'}{'sub': 23', '24', '25', '26', '27', '3', '19, 'R, R, R, R, and R, are independently hydrogen or —(C═O)—(C-C)alkyl;'}{'sub': 4', '1', '20, 'Ris hydrogen or —(C-C)alkyl;'}{'sub': 41', '4', '20, 'Ris independently hydrogen or —(C-C)alkyl; and'}{'sub': 42', '43', '44', '3', '19', '21', '22', '23', '24', '25', '26', '27', '41', '42', '43', '44, 'R, R, and Rare independently hydrogen or —(C═O)—(C-Calkyl, wherein at least one of R, R, R, R, R, R, R, R, R, R, and Ris not hydrogen.'}36.-. (canceled)7. The compound of claim 1 , wherein the the humic acid derivative comprises formula VI claim 1 , a salt thereof claim 1 , or chelate thereof.89.-. (canceled)10. The compound of claim 1 , wherein Ris methyl.11. The compound of claim 1 , wherein R claim 1 , R claim 1 , are independently hydrogen or —(C-C)alkyl.12. The compound of claim 1 , wherein R claim 1 , R claim 1 , R claim 1 , R claim 1 , and R claim 1 , are independently hydrogen or —(C═O)—(C-C)alkyl; and wherein at least one of R claim 1 , R claim 1 , R claim 1 , R claim 1 , R claim 1 , R claim 1 , and Ris not hydrogen.13. The compound of claim 1 , wherein the humic acid derivative is formula VII claim 1 , a salt thereof claim 1 , or chelate thereof.1416.-. (canceled)17. The compound of claim 1 , ...

3,6-disubstituted xanthylium salts

Described are a compound of formula (II) or (III): The compounds are effective in the treatment of disease, including a tauopathy condition or a disease of tau protein aggregation.

ENAMINE COMPOUND AND USE THEREOF

Provided are a donor-acceptor type compound having a novel structure and its use. 2: The enamine compound of claim 1 , wherein Rrepresents a group selected from a halogen atom claim 1 , a nitro group claim 1 , an acyl group claim 1 , a formyl group claim 1 , a cyano group claim 1 , a hydrocarbon oxycarbonyl group claim 1 , a carboxamide group which may comprise a substituent claim 1 , a perfluoroalkyl group claim 1 , a dicyanoethenyl group claim 1 , a Lewis acid residue claim 1 , an aromatic heterocyclic group claim 1 , and a group represented by -A-C(R)═CH—N(R)(R) claim 1 ,wherein{'sup': '1', 'Arepresents a single bond, a divalent aromatic hydrocarbon group which may comprise a substituent, a divalent aromatic heterocyclic group which may comprise a substituent or a divalent unsaturated aliphatic hydrocarbon group which may comprise a substituent;'}{'sup': '5', 'Rrepresents a hydrogen atom or a hydrocarbon group which may comprise a substituent,'}{'sup': 6', '7', '6', '7, 'Rand Rare the same or different from each other and represent an aromatic hydrocarbon group which may comprise a substituent or an aromatic heterocyclic group which may comprise a substituent, or Rand Rtogether form a bicyclic aromatic heterocyclic group which may comprise a substituent and comprises two or more nitrogen atoms or a nitrogen atom and an oxygen atom or a sulfur atom, or a tricyclic aromatic heterocyclic group which may comprise a substituent, and'}{'sup': 5', '1', '5', '6, 'Rand A, or Rand Rmay together form a cyclic structure.'}3: The enamine compound of claim 1 , wherein Rrepresents a hydrogen atom claim 1 , an aliphatic hydrocarbon group which may comprise a substituent claim 1 , or an aromatic hydrocarbon group which may comprise a substituent.4: The enamine compound of claim 1 , wherein Rrepresents a hydrogen atom claim 1 , an alkyl group having 1 to 6 carbon atoms claim 1 , or an aromatic hydrocarbon group having 6 to 10 carbon atoms.5: The enamine compound of claim 1 , ...

ELECTROCHROMIC COMPOUND, ELECTROCHROMIC COMPOSITION, AND ELECTROCHROMIC DISPLAY ELEMENT

Provided is an electrochromic compound represented by the following general formula (I) or (II) where Rto Rare each independently a hydrogen atom, a halogen atom, a monovalent organic group, or a polymerizable functional group, and at least one of the Rto the Ris a polymerizable functional group. 2: The electrochromic compound according to claim 1 , wherein the monovalent organic group is an alkyl group claim 1 , an alkenyl group claim 1 , an alkynyl group claim 1 , an aryl group claim 1 , a heteroaryl group claim 1 , an alkoxy group claim 1 , an aryloxy group claim 1 , or a heteroaryloxy group.3: The electrochromic compound according to claim 1 , wherein Rand Rare each a halogen atom claim 1 , a monovalent organic group claim 1 , or a polymerizable functional group.4: The electrochromic compound according to claim 1 , wherein the polymerizable functional group is an alkyl group claim 1 , an aryl group claim 1 , or an aryl group substituted with an alkyl group.5: The electrochromic compound according to claim 1 , wherein the polymerizable functional group is an acryloyl group or a methacryloyl group.6: An electrochromic composition comprising:{'claim-ref': {'@idref': 'CLM-00001', 'claim 1'}, 'the electrochromic compound according to ; and'}a polymerizable compound different from the electrochromic compound.7. (canceled)8: The electrochromic compound according to claim 1 , represented by the formula (I).9: The electrochromic compound according to claim 1 , represented by the formula (II). The present disclosure relates to electrochromic compounds, electrochromic compositions, and electrochromic display elements.Electrochromism is a phenomenon where an oxidation-reduction reaction is reversibly caused to reversibly change a color by applying voltage. An electrochromic material exhibiting the electrochromism is typically formed between two facing electrodes, and an oxidation-reduction reaction of the electrochromic material is caused in a structure where a space ...

Ligand Compound, Transition Metal Compound, And Catalyst Composition Including The Same

The present invention provides a novel ligand compound, a transition metal compound and a catalyst composition including the same.

ANTIOXIDANT HUMIC ACID DERIVATIVES AND METHODS OF PREPARATION AND USE

Disclosed are antioxidative, natural compounds, their salts, chelates and cleavage derivatives that exhibit a superior combination of properties. The compounds can be used for a variety of purposes, including stabilizing foods, cosmetics, beverages and nutritional supplement. The compounds can be prepared by substantially cleaving a humic acid of formula I to provide at least one antioxidant compounds of formula II, formula III, formula IV, formula V, formula VI, salts, or chelates thereof. 2. The antioxidant compound of claim 1 , wherein the compound is formula II claim 1 , a salt claim 1 , or chelate thereof.3. The antioxidant compound of claim 1 , wherein the compound is formula III claim 1 , a salt claim 1 , or chelate thereof.4. The antioxidant compound of claim 1 , wherein the compound is formula IV claim 1 , a salt claim 1 , or chelate thereof.5. The antioxidant compound of claim 1 , wherein the compound is formula V claim 1 , a salt claim 1 , or chelate thereof.6. The antioxidant compound of claim 1 , wherein the compound is formula VI claim 1 , a salt claim 1 , or chelate thereof.7. The antioxidant compound of any one of claim 1 , claim 1 , claim 1 , and claim 1 , wherein Ris a (C-Co)alkyl.8. The antioxidant compound of any one of - claim 1 , and - claim 1 , wherein Ris hydrogen.9. The antioxidant compound of any one of - claim 1 , and - claim 1 , wherein Ris iodide.10. The antioxidant compound of any one of - claim 1 , and - claim 1 , wherein Ris hydroxyl.11. The antioxidant compound of any one of - claim 1 , wherein the compound is a lithium salt claim 1 , sodium salt claim 1 , ammonium salt claim 1 , potassium salt claim 1 , calcium salt claim 1 , barium salt claim 1 , magnesium salt claim 1 , manganese salt claim 1 , zinc salt claim 1 , aluminum salt claim 1 , iron salt claim 1 , or a combination thereof.12. The antioxidant compound of any one of - claim 1 , wherein the compound is a sodium salt claim 1 , potassium salt claim 1 , calcium salt claim 1 , ...

PHENANTHRENE COMPOUNDS FOR ORGANIC ELECTRONIC DEVICES

The invention relates to specific phenanthrenes, the use of the compound in an electronic device, and an electronic device containing at least one of said compounds. The invention further relates to a method for producing the compound and a formulation and composition containing one or more of the compounds. 117.-. (canceled)24. The compound according to claim 23 , wherein Y is C(R)or NR.25. The compound according to claim 18 , wherein L is a single bond claim 18 , so that the amine group is bonded directly to the phenanthrene.26. The compound according to claim 18 , wherein the compound contains in total at least 26 ring atoms.27. The compound according to claim 18 , wherein the compound contains only one amine group.28. A process for the preparation of the compound according to which comprises a one-step Buchwald coupling by reaction of a phenanthrene derivative which contains a leaving group with Ar—NH—Ar.29. A process for the preparation of the compound according to which comprises a two-step Buchwald coupling by stepwise reaction of a phenanthrene derivative which contains a leaving group with (1) Ar—NHand (2) NH—Ar.30. An oligomer claim 18 , polymer or dendrimer containing one or more compounds according to claim 18 , where the bond(s) to the polymer claim 18 , oligomer or dendrimer is optionally localised at any desired positions in formula (1) which are substituted by R claim 18 , Ror R.31. A composition comprising one or more compound according to and at least one further organically functional material selected from the group consisting of fluorescent emitters claim 18 , phosphorescent emitters claim 18 , host materials claim 18 , matrix materials claim 18 , electron-transport materials claim 18 , electron-injection materials claim 18 , hole-conductor materials claim 18 , hole-injection materials claim 18 , electron-blocking materials and hole-blocking materials.32. A formulation comprising at least one compound according to and at least one solvent.33. An ...

CARBAZOLE AND ACRIDINE PHOTOREDOX CATALYSTS FOR SMALL MOLECULE AND MACROMOLECULAR TRANSFORMATIONS

The present invention provides photocatalysts, methods for their preparation, and methods for preparing linear polymers with high propagation rate. 2. The compound of claim 1 , wherein R claim 1 , R claim 1 , R claim 1 , R claim 1 , R claim 1 , and Rare independently selected from a group consisting of hydrogen claim 1 , C-Csubstituted or unsubstituted alkyl optionally substituted with at least one heteroatom; C-Csubstituted or unsubstituted aryl optionally substituted with at least one heteroatom;{'sub': 7', '1', '6', '6', '14, 'Ris selected from a group consisting of C-Csubstituted or unsubstituted alkyl optionally substituted with at least one heteroatom; C-Csubstituted or unsubstituted aryl optionally substituted with at least one heteroatom;'}{'sub': 8', '9', '6', '20, 'Rand Rare independently selected from a group consisting of C-Csubstituted or unsubstituted aryl optionally substituted with at least one heteroatom;'}{'sub': 10', '11, 'Y is O, CRR, or absent; and'}{'sub': 10', '11', '1', '6', '6', '14, 'Rand Rare independently selected from a group consisting of hydrogen, C-Csubstituted or unsubstituted alkyl optionally substituted with at least one heteroatom; and C-Csubstituted or unsubstituted aryl optionally substituted with at least one heteroatom.'}3. The compound of claim 1 , wherein R claim 1 , R claim 1 , R claim 1 , R claim 1 , R claim 1 , and Rare independently selected from a group consisting of hydrogen claim 1 , C-Csubstituted or unsubstituted alkyl optionally substituted with at least one heteroatom; C-Csubstituted or unsubstituted aryl optionally substituted with at least one hetero atom;{'sub': 7', '1', '4', '6', '14, 'Ris selected from a group consisting of C-Csubstituted or unsubstituted alkyl optionally substituted with at least one heteroatom; C-Csubstituted or unsubstituted aryl optionally substituted with at least one heteroatom;'}{'sub': 8', '9', '6', '20, 'Rand Rare independently selected from a group consisting of C-Csubstituted or ...

HUMIC ACID DERIVATIVES AND METHODS OF PREPARATION AND USE

Disclosed are antioxidative natural compounds, their salts, chelates and cleavage derivatives that exhibit a superior combination of properties. The compounds can be used for a variety of purposes, including the stabilization of polymers. The compounds can be prepared by substantially cleaving a humic acid of formula I followed by esterification to provide at least one antioxidant compounds of formula V, formula VI, formula VII, formula VIII, salts thereof, or chelates thereof. 2. The compound of claim 1 , comprising at least one compound of formula VI claim 1 , formula VII claim 1 , formula VIII claim 1 , a salt thereof claim 1 , chelate thereof claim 1 , or combination thereof claim 1 ,wherein{'sub': 2', '1', '20, 'Ris hydrogen or —(C-C)alkyl;'}{'sub': 23', '24', '25', '26', '27', '3', '19, 'claim-text': [{'sub': 4', '1', '20, 'Ris hydrogen or —(C-C)alkyl;'}, {'sub': 41', '4', '20, 'Ris independently hydrogen or —(C-C)alkyl; and'}, {'sub': 42', '43', '44', '3', '19, 'R, R, and Rare independently hydrogen or —(C═O)—(C-C)alkyl,'}], 'R, R, R, R, and R, are independently hydrogen or —(C═O)—(C-C)alkyl;'}{'sub': 21', '22', '23', '24', '25', '26', '27', '41', '42', '43', '44, 'wherein at least one of R, R, R, R, R, R, RR, R, Rand Ris not hydrogen.'}3. The compound of claim 1 , wherein the compound is formula V claim 1 , a salt thereof claim 1 , or chelate thereof.4. The compound of wherein{'sub': 11', '111', '112', '111', '112', '1', '20', '1', '20', '3', '19', '3', '19, 'Ris —N(R)(R), wherein Ris C-acetamido or substituted C-acetamido; Ris hydrogen, —(C-C)alkyl, substituted —(C-C)alkyl, —(C═O)—(C-C)alkyl, or substituted —(C═O)—(C-C)alkyl;'}{'sub': 12', '141', '142', '143', '144', '4', '20', '4', '20, 'R, R, R, R, and Rare independently hydrogen, —(C-C)alkyl, or substituted —(C-C)alkyl;'}{'sub': 13', '1', '20', '1', '20', '3', '19', '3', '19, 'Ris hydrogen, —(C-C)alkyl, substituted —(C-C)alkyl, —(C═O)—(C-C)alkyl, or substituted —(C═O)—(C-C)alkyl;'}{'sub': 151', '152', ' ...

CONTROLLING ZONES OF ELECTRONIC DEVICES ASSOCIATED WITH POWER LINES

Methods, systems, and apparatus for monitoring and controlling electronic devices using wired and wireless protocols are disclosed. The systems and apparatus may monitor their environment for signals from electronic devices. The systems and apparatus may take and disambiguate the signals that are received from the devices in their environment to identify the devices and associate control signals with the devices. The systems and apparatus may use communication means to send control signals to the identified electronic devices. Multiple apparatuses or systems may be connected together into networks, including mesh networks, to make for a more robust architecture. 1. A system , comprising:a first control apparatus comprising:a memory that stores instructions; determining which control apparatus of a plurality of control apparatuses including the first control apparatus has a strongest communication link with a remote device; and', 'facilitating relaying of data from the plurality of control apparatuses to the remote device through the control apparatus having the strongest communication link., 'a processor that executes the instructions to perform operations, the operations comprising2. The system of claim 1 , wherein the operations further comprise establishing a communication link between the control apparatus having the strongest communication link and at least one other control apparatus of the plurality of control apparatuses.3. The system of claim 1 , wherein the first control apparatus is configured to couple to a conductor in a power line associated with an electronic device receiving power from the power line.4. The system of claim 3 , wherein the operations further comprise redirecting the power from the conductor through the first control apparatus and to the electronic device.5. The system of claim 1 , wherein the operations further comprise determining claim 1 , after a period of time claim 1 , that a different control apparatus of the plurality of ...

LIGHT EMITTING DEVICES AND COMPOUNDS

Thermally Activated Delayed Fluorescence (TADF) compounds wherein two aromatic heterocyclic moieties are provided as acceptor groups, spaced apart from two donor moieties by an aromatic spacer ring, are described. Charged organic TADF species having a similar structure are also described. The TADF compounds and charged organic TADF species may be employed as emitter material in light emitting devices such as OLEDs and LEECs. Also described TADF compounds wherein at least one donor moiety is substituted by at least one substituent that is a phosphine oxide or a phosphine sulphide. 137-. (canceled)44. A light emitting device comprising a TADF compound according to .45. The light emitting device of claim 44 , wherein said light emitting device is an OLED.492. The TADF compound according to claim 46 , wherein the acceptor moieties Acc are claim 46 , independently for each occurrence selected from the group consisting of -Het as defined in claim claim 46 , —CN claim 46 , sulfone claim 46 , sulfoxide claim 46 , imine claim 46 , amide claim 46 , acridine claim 46 , acridinium claim 46 , carboxylate ester claim 46 , phosphine oxide claim 46 , phosphine sulfide claim 46 , ketone and aldehyde.52. A light emitting device comprising a TADF compound according to .53. The light emitting device of claim 52 , wherein said light emitting device is an OLED.57. The charged organic species according to claim 56 , wherein at least one linking group L is present and is independently for each occurrence claim 56 , a hydrocarbylene chain claim 56 , that may be substituted or unsubstituted claim 56 , hydrocarbylene or unsaturated hydrocarbylene.58. The charged organic species according to claim 57 , wherein the at least one linking group L is selected from substituted or unsubstituted cyclopentane-1 claim 57 ,3-diyl claim 57 , cyclohexane-1 claim 57 ,4-diyl claim 57 , 1 claim 57 ,4-phenylene and 4 claim 57 ,4′-biphenylene.59. The charged organic species according to claim 57 , wherein the ...

LIGHT-EMITTING MATERIAL AND ORGANIC LIGHT-EMITTING DEVICE

A light-emitting material containing a compound represented by the following general formula in a light-emitting layer has high light emission efficiency. In the following general formula, Rto Rrepresent a hydrogen atom or a substituent, provided that at least one of Rto Rrepresents an aryl group, a diarylamino group or a 9-carbazolyl group. 6. The light-emitting material according to claim 1 , wherein in the general formula (1) claim 1 , Rto Reach independently represent a hydrogen atom claim 1 , a substituted or unsubstituted alkyl group claim 1 , a substituted or unsubstituted alkoxy group claim 1 , a substituted or unsubstituted aryl group claim 1 , a substituted or unsubstituted diarylamino group or a substituted or unsubstituted 9-carbazolyl group.7. The light-emitting material according to claim 1 , wherein in the general formula (1) claim 1 , Rto Reach independently represent a hydrogen atom claim 1 , a substituted or unsubstituted alkyl group claim 1 , a substituted or unsubstituted alkoxy group claim 1 , a substituted or unsubstituted diarylamino group or a substituted or unsubstituted 9-carbazolyl group claim 1 , provided that at least one of Rto Rrepresents a substituted or unsubstituted diarylamino group or a substituted or unsubstituted 9-carbazolyl group.8. The light-emitting material according to claim 1 , wherein in the general formula (1) claim 1 , Rto Reach independently represent a hydrogen atom claim 1 , a substituted or unsubstituted diarylamino group or a substituted or unsubstituted 9-carbazolyl group claim 1 , provided that at least one of Rto Rrepresents a substituted or unsubstituted diarylamino group or a substituted or unsubstituted 9-carbazolyl group.14. An organic light-emitting device comprising a substrate having thereon a light-emitting layer containing the light-emitting material according to .16. The organic delayed-fluorescent-light-emitting device according to claim 15 , which is an organic electroluminescent device. The present ...

PHENOXAZINE DERIVATIVES AND METHODS OF USE THEREOF

The present invention encompasses phenoxazine derivatives and methods of use thereof. 2. The compound of claim 1 , wherein Ris (CH).3. The compound of claim 1 , wherein Ris ((CH)O).4. The compound of claim 1 , wherein Ris ((CH)O(CH)).5. The compound of claim 1 , wherein Ris a cyclic ring.6. The compound of claim 1 , wherein Ris a heterocyclic ring.8. The compound of claim 7 , wherein Ris ((CH)O).9. The compound of claim 8 , wherein Ris hydrogen.10. The compound of claim 8 , wherein Ris a hydrocarbyl.11. The compound of claim 8 , wherein Ris a substituted hydrocarbyl.12. The compound of claim 7 , wherein Ris ((CH)O(CH)).13. The compound of claim 8 , wherein Ris hydrogen.14. The compound of claim 8 , wherein Ris a hydrocarbyl.15. The compound of claim 8 , wherein Ris a substituted hydrocarbyl.17. The compound of claim 16 , wherein Ris a halogen.18. The compound of claim 16 , wherein Ris an alkenyl group.19. The compound of claim 16 , wherein Ris an alkynyl group.20. The compound of claim 16 , wherein Ris a substituted hydrocarbyl. This application is a continuation of U.S. patent application Ser. No. 13/195,344, filed Aug. 1, 2011, which claims the priority of U.S. Provisional Application No. 61/369,364, filed Jul. 30, 2010, each of which are incorporated herein by reference in its entirety.The invention encompasses phenoxazine derivatives and methods of use thereof.Cerebral amyloid angiopathy (CAA) is almost universally noted in patients with Alzheimer's Disease (AD) (˜90% of individuals) and is commonly found in non-AD elderly individuals (˜30% of those >60 years of age). It is characterized by amyloid-β (Aβ) deposition in cortical cerebral arterioles. CAA is a powerful risk factor for three potentially interrelated diseases: 1) cerebral hemorrhage, 2) ischemic brain injury, and 3) dementia. Though substantial mechanistic and therapeutic progress has been made in preclinical studies (including identification of several interventions that can halt or even reverse CAA ...

SPIROBIFLUORENE COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT DEVICES

The present invention relates to compounds of the formula (1) which are suitable for use in electronic devices, in particular organic electroluminescent devices, and to electronic devices which comprise these compounds. 115.-. (canceled)17. The compound according to claim 16 , wherein the index i is 0.21. The compound according to claim 16 , wherein groups Arand Arare claim 16 , identically or differently on each occurrence claim 16 , selected from the group consisting of the formulae (11) claim 16 , (13) claim 16 , (16) claim 16 , (20) claim 16 , (28) claim 16 , (29) claim 16 , (33) claim 16 , (34) claim 16 , (35) claim 16 , (37) claim 16 , (38) claim 16 , (39) claim 16 , (40) claim 16 , (44) claim 16 , (48) claim 16 , (49) claim 16 , (51) claim 16 , and (59).22. The compound according to claim 16 , wherein groups Arand Arare claim 16 , identically or differently on each occurrence claim 16 , selected from the group consisting of the formulae (11) claim 16 , (13) claim 16 , (20) claim 16 , (29) claim 16 , (35) claim 16 , (38) claim 16 , (39) claim 16 , (49) claim 16 , (51) claim 16 , and (59).23. The compound according to claim 16 , wherein the groups Arand Arare selected identically.24. The compound according to claim 16 , wherein Rto Rare selected claim 16 , identically or differently on each occurrence claim 16 , from the group consisting of H claim 16 , F claim 16 , CN claim 16 , a straight-chain alkyl or alkoxy group having 1 to 10 C atoms or a branched or cyclic alkyl or alkoxy group having 3 to 10 C atoms claim 16 , each of which may be substituted by one or more radicals R claim 16 , where one or more non-adjacent CHgroups may be replaced by O and where one or more H atoms may be replaced by F claim 16 , an aromatic or heteroaromatic ring system having 6 to 24 aromatic ring atoms claim 16 , which may in each case be substituted by one or more radicals R.25. The compound according to claim 16 , wherein the radical Rwhich is bonded to Aror Aror Aris selected ...

Organic electro-luminescent element and bioinstrumentation device

An organic electro-luminescent element having a luminescence peak in a near-infrared range, comprising a positive electrode, a negative electrode, and at least one organic layer including a luminescent layer located between the positive electrode and the negative electrode, wherein the luminescent layer comprises a host material, a delayed fluorescent material and a luminescent material, wherein each of the delayed fluorescent material and the luminescent material have a structure with two or three benzene rings bonded to an N atom.

ALKOXYLATED HUMUS MATERIAL COMPOSITIONS AND METHODS OF MAKING SAME

A method of alkoxylating a humus material comprising heating a reaction mixture comprising a humus material, a C3+ cyclic ether, a catalyst and an inert reaction solvent, and recovering a C3+ alkoxylated humus material from the reaction mixture. A method of alkoxylating a humus material comprising heating a reaction mixture comprising a humus material, a C3+ cyclic ether, a catalyst and an inert reaction solvent to a temperature of from about 130° C. to about 170° C., wherein the humus material comprises leonardite, the C3+ cyclic ether comprises propylene oxide, and the inert reaction solvent comprises xylene, and recovering a C3+ alkoxylated humus material from the reaction mixture. A C3+ alkoxylated humus material. 1. A method of alkoxylating a humus material comprising:heating a reaction mixture comprising a humus material, a C3+ cyclic ether, a catalyst and an inert reaction solvent; andrecovering a C3+ alkoxylated humus material from the reaction mixture.24-. (canceled)68-. (canceled)1112-. (canceled)13. The method of wherein the strong base catalyst comprises sodium methoxide claim 23 , potassium methoxide claim 23 , sodium ethoxide claim 23 , potassium ethoxide claim 23 , or combinations thereof.1415-. (canceled)16. The method of wherein the strong acid catalyst comprises (a) a mixture of HF and at least one of a metal alkoxide and a mixed metal alkoxide; or (b) a mixture of esters of at least one of titanic and zirconic acid with monoalkanols and at least one of sulfuric acid claim 23 , alkanesulfonic acids and aryloxysulfonic acids.18. The method of wherein the inert reaction solvent comprises C-Cliquid aromatic hydrocarbons.19. The method of wherein the C-Cliquid aromatic hydrocarbon is selected from the group consisting of toluene claim 18 , ethylbenzene claim 18 , xylenes claim 18 , o-xylene claim 18 , m-xylene claim 18 , p-xylene claim 18 , trimethylbenzenes claim 18 , cumene claim 18 , mesitylene claim 18 , 1 claim 18 ,2 claim 18 ,4-trimethylbenzene ...

PHENOXAZINE DERIVATIVES AND METHODS OF USE THEREOF

The present invention encompasses phenoxazine derivatives and methods of use thereof. 2. The compound of claim 1 , wherein Ris (CH).3. The compound of claim 1 , wherein Ris ((CH)O).4. The compound of claim 1 , wherein Ris ((CH)O(CH)).5. The compound of claim 1 , wherein Ris a cyclic ring.6. The compound of claim 1 , wherein Ris a heterocyclic ring.8. The compound of claim 7 , wherein Ris ((CH)O).9. The compound of claim 8 , wherein Ris hydrogen.10. The compound of claim 8 , wherein Ris a hydrocarbyl.11. The compound of claim 8 , wherein Ris a substituted hydrocarbyl.12. The compound of claim 7 , wherein Ris ((CH)O(CH)).13. The compound of claim 8 , wherein Ris hydrogen.14. The compound of claim 8 , wherein Ris a hydrocarbyl.15. The compound of claim 8 , wherein Ris a substituted hydrocarbyl.17. The compound of claim 16 , wherein Ris a halogen.18. The compound of claim 16 , wherein Ris an alkenyl group.19. The compound of claim 16 , wherein Ris an alkynyl group.20. The compound of claim 16 , wherein Ris a substituted hydrocarbyl. This application is a continuation of U.S. patent application Ser. No. 14/251,072, filed Apr. 11, 2014, which is a continuation of U.S. patent application Ser. No. 13/195,344, filed Aug. 1, 2011, now U.S. Pat. No. 8,735,575 issued on May 27, 2014, which claims the priority of U.S. Provisional Application No. 61/369,364, filed Jul. 30, 2010, each of which are incorporated herein by reference in its entirety.The invention encompasses phenoxazine derivatives and methods of use thereof.Cerebral amyloid angiopathy (CAA) is almost universally noted in patients with Alzheimer's Disease (AD) (˜90% of individuals) and is commonly found in non-AD elderly individuals (˜30% of those >60 years of age). It is characterized by amyloid-β (Aβ) deposition in cortical cerebral arterioles. CAA is a powerful risk factor for three potentially interrelated diseases: 1) cerebral hemorrhage, 2) ischemic brain injury, and 3) dementia. Though substantial mechanistic ...

ORGANIC ELECTROLUMINESCENT DEVICE AND MANUFACTURING METHOD THEREOF

Disclosed is an organic electroluminescent device, comprising a substrate and light emitting units formed in sequence on the substrate, characterized in that, each of the light emitting units comprises a first electrode layer (), a light emitting layer () and a second electrode layer (), the light emitting layer comprises a host material and a dye, the host material is made of materials having both electron transport capability and hole transport capability; at least one material in the host material has a CT excited triplet state energy level Tgreater than its n-π excited triplet state energy level S, and T-S≤0.3 eV; or, at least one material in the host material has a CT excited triplet state energy level Tgreater than its n-π excited triplet state energy level S, and T-S≥1 eV, with the difference between its n-π excited second triplet state energy level and its CT excited first singlet state energy level being in the range of −0.1 eV to 0.1 eV. The organic electroluminescent device configuration can sufficiently utilize the triplet state energy in the host material and the dye to increase the luminous efficiency and prolong the service life of the device. 1123. An organic electroluminescent device , comprising a substrate and light emitting units formed in sequence on the substrate , wherein each of the light emitting units comprises a first electrode layer () , a light emitting layer () and a second electrode layer () , the light emitting layer comprises a host material and a dye ,the host material is made of materials having both electron transport capability and hole transport capability;{'sub': 1', '1', '1', '1, 'at least one material in the host material has a CT excited triplet state energy level Tgreater than its n-π excited triplet state energy level S, and T-S≤0.3 eV; or'}{'sub': 1', '1', '1', '1, 'at least one material in the host material has a CT excited triplet state energy level Tgreater than its n-π excited triplet state energy level S, and T-S≥1 ...

COMPOUNDS FOR ELECTRONIC DEVICES

The present invention relates to a compound of the formula (I), to the use of this compound in an electronic device, and to an electronic device comprising one or more compounds of the formula (I). The invention furthermore relates to the preparation of the compound of the formula (I) and to a formulation comprising one or more compounds of the formula (I). 115.-. (canceled)17. The compound of claim 16 , wherein the groups Arof group A of formula (II) are identically or differently on each occurrence claim 16 , an aryl group having 6 to 10 aromatic ring atoms.18. The compound of claim 16 , wherein the group A is identically or differently on each occurrence claim 16 , of the formula (II) claim 16 , and each of the groups Arare connected via the group Y.21. The compound of claim 16 , wherein Y is selected from a single bond claim 16 , C(R) claim 16 , NR claim 16 , O claim 16 , or S.22. The compound of claim 18 , wherein Y is selected from a single bond claim 18 , C(R) claim 18 , NR claim 18 , O claim 18 , or S.23. The compound of claim 16 , wherein the group Ris claim 16 , identically or differently on each occurrence claim 16 , F or CN.24. The compound of claim 16 , wherein the radicals Rin formula (I) are selected identically.25. The compound of claim 23 , wherein the radicals Rin formula (I) are selected identically.27. An oligomer claim 16 , polymer claim 16 , or dendrimer claim 16 , comprising one or more compounds of claim 16 , wherein bonds to the oligomer claim 16 , polymer claim 16 , or dendrimer claim 16 , are connected at any position of the formula (I) by R claim 16 , R claim 16 , R.28. A formulation comprising at least one compound of and at least one solvent.29. A formulation comprising at least one oligomer claim 25 , polymer claim 25 , or dendrimer claim 25 , of and at least one solvent.30. An electronic device comprising at least one compound of claim 16 , wherein the the electronic device is selected from an organic integrated circuit (O-IC) claim ...

Materials for organic electroluminescent devices

The present invention relates to compounds of the formula (1) which are suitable for use in electronic devices, in particular organic electroluminescent devices, and to electronic devices which comprise these compounds.

RESORUFIN DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISORDERS

Disclosed herein are resorufin derivative compounds and methods of using such compounds for treating or suppressing oxidative stress disorders, including mitochondrial disorders, impaired energy processing disorders, neurodegenerative diseases and diseases of aging. 2. The compound of claim 1 , wherein R claim 1 , R claim 1 , and Rare —CH.3. The compound of claim 1 , wherein Rand Rare —CH claim 1 , and Ris —H.4. The compound of claim 1 , wherein Rand Rare —OCH claim 1 , and Ris —CH.5. The compound of claim 1 , wherein Rand Rare —CH claim 1 , and wherein Ris -n-C-Calkyl.6. The compound of claim 1 , wherein Rand Rare —OCH claim 1 , and wherein Ris -n-C-Calkyl.9. The compound of claim 1 , wherein R claim 1 , R claim 1 , and Rare —H.10. The compound of claim 1 , wherein three of R claim 1 , R claim 1 , R claim 1 , and Rare —H.11. The compound of claim 1 , wherein R claim 1 , R claim 1 , R claim 1 , and Rare —H.18. A pharmaceutical formulation comprising a compound according to and a pharmaceutically acceptable excipient.20. The method of claim 19 , wherein the method is a method of treating an oxidative stress disorder selected from the group consisting of: a mitochondrial disorder; an inherited mitochondrial disease; Alpers Disease; Barth syndrome; a Beta-oxidation Defect; Carnitine-Acyl-Carnitine Deficiency; Carnitine Deficiency; a Creatine Deficiency Syndrome; Co-Enzyme Q10 Deficiency; Complex I Deficiency; Complex II Deficiency; Complex III Deficiency; Complex IV Deficiency; Complex V Deficiency; COX Deficiency; chronic progressive external ophthalmoplegia (CPEO); CPT I Deficiency; CPT II Deficiency; Friedreich's Ataxia (FA); Glutaric Aciduria Type II; Kearns-Sayre Syndrome (KSS); Lactic Acidosis; Long-Chain Acyl-CoA Dehydrongenase Deficiency (LCAD); LCHAD; Leigh Disease; Leigh-like Syndrome; Leber's Hereditary Optic Neuropathy (LHON); Lethal Infantile Cardiomyopathy (LIC); Luft Disease; Multiple Acyl-CoA Dehydrogenase Deficiency (MAD); Medium-Chain Acyl-CoA ...

COMPOUND HAVING TRIPHENYLENE RING STRUCTURE, AND ORGANIC ELECTROLUMINESCENT DEVICE

A compound that emits fluorescence and delayed fluorescence is provided as a material for an organic electroluminescent device of high efficiency, and an organic photoluminescent device and an organic electroluminescent device of high efficiency and high luminance are provided using this compound. The compound of a general formula (1) having a triphenylene ring structure is used as a constituent material of at least one organic layer in the organic electroluminescent device that includes a pair of electrodes, and one or more organic layers sandwiched between the pair of electrodes. 6. The compound having a triphenylene ring structure according to claim 1 , wherein X in the general formula (1) claim 1 , (1-1) claim 1 , (1-2) claim 1 , (1-3) claim 1 , or (1-4) is a monovalent group selected from substituted or unsubstituted phenoxazinyl claim 1 , substituted or unsubstituted phenothiazinyl claim 1 , substituted or unsubstituted acridinyl claim 1 , substituted or unsubstituted phenazinyl claim 1 , and carbazolyl having claim 1 , as a substituent claim 1 , a disubstituted amino group substituted with an aromatic hydrocarbon group or a condensed polycyclic aromatic group.7. The compound having a triphenylene ring structure according to claim 1 , wherein Y in the general formula (1) claim 1 , (1-1) claim 1 , (1-2) claim 1 , (1-3) claim 1 , or (1-4) is a monovalent group selected from substituted or unsubstituted phenoxazinyl claim 1 , substituted or unsubstituted phenothiazinyl claim 1 , substituted or unsubstituted acridinyl claim 1 , substituted or unsubstituted phenazinyl claim 1 , and carbazolyl having claim 1 , as a substituent claim 1 , a disubstituted amino group substituted with an aromatic hydrocarbon group or a condensed polycyclic aromatic group.8. The compound having a triphenylene ring structure according to claim 1 , wherein X and Y in the general formula (1) claim 1 , (1-1) claim 1 , (1-2) claim 1 , (1-3) claim 1 , or (1-4) are a monovalent group selected ...

Charge transport material, ink composition using said material, organic electronic element, organic electroluminescent element, display element, lighting device and display device

A charge transport polymer containing a structural unit having an N-aryl phenoxazine skeleton is produced, and is used as a charge transport material.

ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES

The invention relates to an organic molecule having a structure of the formula I 115-. (canceled)17. The organic molecule according to claim 16 , where{'sup': 4', '4', '4', '4, 'sub': '2', 'R′=selected from the group consisting of H, N(R), OR, thiophene, a linear alkyl or alkoxy group having 1 to 40 C atoms and a branched or cyclic alkyl or alkoxy group having 3 to 40 carbon atoms, it being possible for this group to be substituted in each case by one or more radicals R, and an aromatic ring system having 5 to 60 aromatic ring atoms, it being possible for this system to be substituted by one or more radicals R; and'}{'sup': 4', '4', '4', '4, 'sub': '2', 'R″=selected from the group consisting of N(R), OR, thiophene, a linear alkyl or alkoxy group having 1 to 40 C atoms and a branched or cyclic alkyl or alkoxy group having 3 to 40 C atoms, it being possible for this group to be substituted in each case by one or more radicals R, or an aromatic ring system having 5 to 60 aromatic ring atoms, it being possible for this system to be substituted by one or more radicals R.'}20. The organic molecule according to claim 16 , where the accepting unit X of the formula I is CN.21. The organic molecule according to claim 16 , where the accepting unit X of the formula I is CF.22. The organic molecule according to claim 16 , where the radical R′ of the formula I is a hydrogen atom.23. An optoelectronic device comprising the organic molecule according to .24. An optoelectronic device comprising the organic molecule according to .25. The optoelectronic device according to claim 23 , wherein the optoelectronic device is an organic light-emitting diode claim 23 , light-emitting electrochemical cell claim 23 , organic light-emitting sensor claim 23 , an organic diode claim 23 , an organic solar cell claim 23 , an organic transistor claim 23 , an organic field-effect transistor claim 23 , an organic laser or a down-conversion element.26. The optoelectronic device according to claim 23 , ...

PHENANTHRO[9,10-b]TETRAPHENYLENE DERIVATIVE AND USE THEREOF

The present invention discloses a novel phenanthro[9,10-b]tetraphenylene derivative is represented by the following formula(I), the organic EL device employing the phenanthro[9,10-b]tetraphenylene derivative as electron blocking material, hole blocking material, electron transport material, phosphorescent host material, or fluorescent host and dopant material can display good performance. 5. A organic electroluminescent device comprising a pair of electrodes consisting of a cathode and an anode and between the pairs of electrodes comprising at least a layer of the phenanthro[9 claim 1 ,10-b]tetraphenylene derivative with a general formula(I) according to .6. The organic electroluminescent device according to claim 5 , wherein the emitting layer comprising the phenanthro[9 claim 5 ,10-b]tetraphenylene derivative with a general formula(I).7. The organic electroluminescent device according to claim 6 , wherein the emitting layer comprising the phenanthro[9 claim 6 ,10-b]tetraphenylene derivative with a general formula(I) is a fluorescent host material claim 6 , a phosphorescent host material or a thermally activated delayed fluorescence host material.8. The organic electroluminescent device according to claim 6 , wherein the emitting layer comprising fluorescent dopant claim 6 , phosphorescent dopant or thermally activated delayed fluorescence dopant.9. The organic electroluminescent device according to claim 8 , wherein the phosphorescent dopant are iridium (Ir) complexes.10. The organic electroluminescent device according to claim 5 , wherein the electron transport layer comprising the phenanthro[9 claim 5 ,10-b]tetraphenylene derivative with a general formula(I).11. The organic electroluminescent device according to claim 10 , wherein the electron transport layer comprising lithium claim 10 , calcium claim 10 , 8-hydroxyquinolinolato-lithium.12. The organic electroluminescent device according to claim 5 , wherein the hole blocking layer or electron blocking layer ...

REDUNDANT POWER LINE CONTROL SYSTEMS

Methods, systems, and apparatus for monitoring and controlling electronic devices using wired and wireless protocols are disclosed. The systems and apparatus may monitor their environment for signals from electronic devices. The systems and apparatus may take and disambiguate the signals that are received from the devices in their environment to identify the devices and associate control signals with the devices. The systems and apparatus may use communication means to send control signals to the identified electronic devices. Multiple apparatuses or systems may be connected together into networks, including mesh networks, to make for a more robust architecture. 1. A system for controlling electronic devices located at a site , comprising: a processor; and', 'a memory coupled to the processor;', 'wherein the control apparatus is configured to couple to at least one conductor in a power line associated with an electronic device receiving power from the power line, and wherein the control apparatus is configured to redirect electrical power from the at least one conductor through the control apparatus and to the electronic device;, 'a plurality of control apparatus, wherein one or more of the control apparatus comprisewherein a first control apparatus and a second control apparatus are configured to establish a communication link to at least one electronic device located at the site, the communication link comprising at least one of a wireless communication link and a power line communication link; andwherein at least one of the first control apparatus and the second control apparatus is configured to monitor and control the at least one electronic device using the established communication link.2. The apparatus of claim 1 , wherein at least one of the first control apparatus and the second control apparatus are configured to establish a wireless communication link with a remote device.3. The apparatus of claim 2 , wherein the control apparatus having the wireless ...

THERMALLY ACTIVATED DELAYED FLUORESCENCE MATERIAL AND METHOD FOR PREPARING THEREOF AND ORGANIC ELECTROLUMINESCENT DIODE DEVICE

A thermally activated delayed fluorescent (TADF) compound, a method for preparing thereof, and an organic electroluminescent diode device are provided. The thermally activated delayed fluorescent compound includes a chemical structure of formula I: 6. The method for preparing the thermally activated delayed fluorescent compound according to claim 5 , wherein the electron donating compound is 9 claim 5 ,10-dihydro-9 claim 5 ,9-dimethyl acridine claim 5 , phenoxazine or phenothiazine.7. An organic electroluminescent diode device claim 5 , comprising:a substrate;a first electrode disposed on the substrate;an organic functional layer disposed on the first electrode;and a second electrode disposed on the organic functional layer of the first electrode;wherein the organic functional layer comprises an organic film or a multilayered organic film, and at least one of organic film is a luminescent layer; and{'claim-ref': {'@idref': 'CLM-00001', 'claim 1'}, 'wherein luminescent layer comprises the thermally activated delayed fluorescent compound of .'}8. The organic electroluminescent diode device according to claim 7 , wherein the luminescent layer is formed by vacuum evaporation or solution coating.9. The organic electroluminescent diode device according to claim 7 , wherein a material of the luminescent layer is a mixture of a host material and a guest material claim 7 , and the guest material is selected from one or more of the thermally activated delayed fluorescent compounds of .10. The organic electroluminescent diode device according to claim 7 , wherein the substrate is a glass substrate claim 7 , a material of the first electrode is indium tin oxide claim 7 , and the second electrode is a two-layered composite structure made of a lithium fluoride layer and an aluminum layer;wherein the organic functional layer comprises a multilayered organic film, and the multilayered organic film comprises a hole injection layer, a hole transport layer, a luminescent layer, and an ...

3-ARYL PROPIOLONITRILE COMPOUNDS FOR THIOL LABELING

The present invention relates to a process for labeling compounds comprising thiol moieties with 3-arylpropiolonitrile compounds, to 3-arylpropiolonitrile compounds substituted with tag moieties and to specific 3-arylpropiolonitrile linkers. 7. The compound according to claim 6 , wherein the compound of interest is a biomolecule claim 6 , wherein the biomolecule is an antibody or a protein. This application is a divisional of U.S. application Ser. No. 14/899,883, filed Dec. 18, 2015, which is the National Stage of International Application No. PCT/EP2014/064387, filed on Jul. 4, 2014, which claims the benefit of European Application No. 13305950.1, filed Jul. 4, 2013. The contents of which are hereby incorporated by reference in their entirety.The present invention relates to a process for labeling compounds comprising thiol moieties with 3-arylpropiolonitrile compounds, to 3-arylpropiolonitrile compounds substituted with tag moieties and to specific 3-arylpropiolonitrile linkers.Over 90% of the human proteins contain cysteines, while in silico digest of the human proteome revealed that only about 15% of all human tryptic peptides detectable by mass spectroscopy (MS) contain at least one cysteine in their sequence. This observation combined with the presence of a highly reactive thiol group on its side chain makes cysteine an attractive target for chemical labeling. Cysteine is the only coded amino acid that carries a nucleophilic sulfhydryl (or thiol) group (—SH), which largely exceeds the reactivity of any other nucleophilic function susceptible to be present in proteins. As a result, chemospecific cysteine derivatization is by far the most widely used method for chemical tagging of proteins. Among the vast number of chemical cysteine modification methods reported in literature so far, reagents such as N-substituted maleimides, 4-vinylpyridines and iodoacetamides are most commonly used. All of them possess drawbacks preventing them from being ideal methodology for ...

AMINE DERIVATIVES, MATERIAL FOR ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME AND ORGANIC ELECTRLUMINESCENT DEVICE USING THE SAME

A novel amine derivative is represented by the following Formula 1: 2. The amine derivative of claim 1 , wherein Lis selected from a substituted or unsubstituted arylene group having 6 to 30 carbon atoms for forming a ring and a substituted or unsubstituted heteroarylene group having 2 to 30 carbon atoms for forming a ring.3. The amine derivative of claim 1 , wherein Arand Arare each independently selected from a group substituted with a substituent not including a nitrogen atom claim 1 , and an unsubstituted aryl group or heteroaryl group claim 1 , the aryl group or the heteroaryl group not including a nitrogen atom.5. The amine derivative of claim 4 , whereins in Formula 2 is the same as m in Formula 1,r in Formula 2 is the same as n in Formula 1, andt in Formula 2 is the same as p in Formula 1.8. The material for an organic EL device of claim 7 , wherein Lis selected from a substituted or unsubstituted arylene group having 6 to 30 carbon atoms for forming a ring and a substituted or unsubstituted heteroarylene group having 2 to 30 carbon atoms for forming a ring.9. The material for an organic EL device of claim 7 , wherein Arand Arare each independently selected from a group substituted with a substituent not including a nitrogen atom and an unsubstituted aryl group or heteroaryl group claim 7 , the aryl group or the heteroaryl group not including a nitrogen atom.11. The material for an organic EL device of claim 10 , whereins in Formula 2 is the same as m in Formula 1,r in Formula 2 is the same as n in Formula 1, andt in Formula 2 is the same as p in Formula 1.14. The organic EL device of claim 13 , wherein Lis selected from a substituted or unsubstituted arylene group having 6 to 30 carbon atoms for forming a ring and a substituted or unsubstituted heteroarylene group having 2 to 30 carbon atoms for forming a ring.15. The organic EL device of claim 13 , wherein Arand Arare each independently selected from a group substituted with a substituent not including a ...

Mediator For Test Sensor

A method of forming a 3-phenylimino-3H-phenothiazine or a 3-phenylimino-3H-phenoxazine mediator includes providing a first reactant including phenothiazine or phenoxazine, providing a first solvent, providing a second reactant and providing a second solvent. The first reactant, first solvent, second reactant and second solvent are combined to form a reactants solution. Sodium persulfate is added to the reactants solution to couple the first and second reactants resulting in a reaction solution including the 3-phenylimino-3H-phenothiazine or the 3-phenylimino-3H-phenoxazine mediator.

Polymeric Compounds And Methods Of Making And Using The Same

The present disclosure provides compounds, or pharmaceutically acceptable salts thereof, for inhibiting the growth of a microbe; treating a mammal having a microbial infection, malaria, mucositis, an ophthalmic infection, an otic infection, a cancer, or a infection; killing or inhibiting the growth of a species; inhibiting the growth of a species; modulating an immune response in a mammal; or antagonizing unfractionated heparin, low molecular weight heparin, or a heparin/low molecular weight heparin derivative. 28-. (canceled)1018-. (canceled)2023-. (canceled)2542-. (canceled)4448-. (canceled)5057-. (canceled)5971-. (canceled)7385-. (canceled)87105-. (canceled)107117-. (canceled)119125-. (canceled)127136-. (canceled)138149-. (canceled)151160-. (canceled)162173-. (canceled)175196-. (canceled)198218-. (canceled)220232-. (canceled)234244-. (canceled)246257-. (canceled)258. A pharmaceutical composition comprising a compound of claim 1 , or a pharmaceutically acceptable salt thereof claim 1 , and a pharmaceutically acceptable carrier.259263-. (canceled)264. A method of inhibiting the growth of a microbe comprising contacting the microbe with a compound claim 1 , or pharmaceutically acceptable salt thereof claim 1 , of .265. A method of treating a mammal having a microbial infection comprising administering to the mammal in need thereof an anti-microbial effective amount of a compound claim 1 , or pharmaceutically acceptable salt thereof claim 1 , of .266271-. (canceled)272. A method of treating malaria in a mammal comprising administering to the mammal in need thereof a therapeutically effective amount of a compound of claim 1 , or a pharmaceutically acceptable salt thereof.273. (canceled)274Plasmodium. A method of killing or inhibiting the growth of a species comprising contacting the species with an effective amount of a compound of claim 1 , or a pharmaceutically acceptable salt thereof.275MycobacteriumMycobacterium. A method of inhibiting the growth of a species ...

SPIROBIFLUORENE DERIVATIVES FOR USE IN ELECTRONIC DEVICES

The present application relates to a spirobifluorene derivative of a specific formula (I) which is suitable for use in electronic devices. 2. The compound according to claim 1 , characterized in that Aris selected from divalent groups derived from benzene claim 1 , biphenyl claim 1 , terphenyl claim 1 , naphthyl claim 1 , fluorenyl claim 1 , indenofluorenyl claim 1 , spirobifluorenyl claim 1 , dibenzofuranyl claim 1 , dibenzothiophenyl claim 1 , and carbazolyl claim 1 , which may each be substituted by one or more radicals R.3. The compound according to claim 1 , characterized in that groups Arare claim 1 , identically or differently claim 1 , selected from radicals derived from the groups phenyl claim 1 , biphenyl claim 1 , terphenyl claim 1 , quaterphenyl claim 1 , naphthyl claim 1 , fluorenyl claim 1 , benzofluorenyl claim 1 , spirobifluorenyl claim 1 , indenofluorenyl claim 1 , dibenzofuranyl claim 1 , dibenzothiophenyl claim 1 , carbazolyl claim 1 , benzofuranyl claim 1 , benzothiophenyl claim 1 , indolyl claim 1 , quinolinyl claim 1 , pyridyl claim 1 , pyrimidyl claim 1 , pyrazinyl claim 1 , pyridazinyl and triazinyl claim 1 , which are each optionally substituted by one or more radicals R claim 1 , or from combinations of 2 or 3 radicals derived from these groups claim 1 , which are each optionally substituted by one or more radicals R.4. The compound according to claim 1 , characterized in that index m is 0.7. The compound according to claim 1 , characterized in that Ris H.8. The compound according to claim 1 , characterized in that Ris selected claim 1 , identically or differently claim 1 , from H claim 1 , F claim 1 , methyl claim 1 , tert-butyl claim 1 , and phenyl.9. The compound according to claim 1 , characterized in that the group Zwhich is located in the ortho-position to the bond between the two six-rings is CR claim 1 , and the other groups Zare CR.11. A process for preparation of the compound according to claim 1 , characterized in that it ...

PHENYL DERIVATIVES SUBSTITUTED WITH AT LEAST TWO ELECTRON ACCEPTORS AND AT LEAST TWO ELECTRON DONORS FOR USE IN ORGANIC ELECTRONIC DEVICES

The present invention relates to a phenyl-derivative compound substituted with at least two electron acceptors and at least two electron donors. Formula (I) RaRbRcCwherein a is 2, 3 or 4; b is 2, 3 or 4; c is 0, 1 or 2; a+b−c=6; Ris at each occurrence independently a group with −M-effect; Ris at each occurrence independently a group with +−M-effect; Ris as defined in claim Said compound is suited for use in organic electronic devices, particularly in organic electroluminescent devices. 111.-. (canceled)12. A compound of general formula (I){'br': None, 'sup': A', 'D', 'S, 'sub': a', 'b', 'c', '6, 'RRRC\u2003\u2003(I)'}whereina is 2, 3 or 4; b is 2, 3 or 4; c is 0, 1 or 2; a+b+c=6;{'sup': 'A', 'Ris at each occurrence independently a group with −M-effect;'}{'sup': 'D', 'Ris at each occurrence independently a group with +−M-effect;'}{'sup': S', '2', '2', '2', '2', '2', '2', '2', '2', '2', '2', '2', '2', '2', '2', '2', '2', '2', '2', '2', '2', '2', '2', '2', '2', '2, 'sub': 2', '2', '2', '3', '2', '2', '2', '2', '2', '2', '2', '2', '2, 'Ris at each occurrence independently selected from the group consisting of is at each occurrence independently selected from the group consisting of H, D, F, Cl, Br, I, B(OR), CHO, C(═O)R, CR═C(R), CN, C(═O)O R, C(═O)N(R), Si(R), N(R), NO, P(═O)(R), OSOR, OR, S(═O)R, S(═O)R, OH, SH, linear alkyl-, alkoxy- or thioalkyl-group with 1 to 20 C-atoms or a branched or cyclic alkyl-, alkoxy- or thioalkyl-group with 3 to 20 C-atoms or a alkenyl- or alkinyl-group with 2 to 20 C-atoms, wherein these groups may be substituted with one or more of groups Rand wherein one or more CH-Gruppen in these groups may be replaced by —RC═CR—, Si(R), C═O, C═S, C═NR, —C(═O)O—, —C(═O)NR—, NR, P(═O)(R), —O—, —S—, SO or SO, and wherein one or more H-atoms in these groups may be replaced by D, F, Cl, Br, I, CN or NO, or an aromatic or heteroaromatic ring system with 5 to 60 aromatic ring atoms, which can be substituted with one or more groups R, or an aryloxy- or ...

STEREOSPECIFIC PROCESS FOR 3-HETEROCYCLYLCYCLOALIPHATIC-1,2-DIOLS

A process for the stereoselective synthesis of chiral 3-heterocyclyl-1,2-dihydroxy cyclohexanes is disclosed. The process involves reacting a tricyclic nitrogenous heterocycle with an allyl carbonate in the presence of a chiral palladium catalyst followed by oxidation of the olefinic bond to provide 3-heterocyclyl-1,2-dihydroxy cyclohexanes, cyclopentanes and corresponding alicyclic heterocycles. Also disclosed are methods for converting the heterocyclyl-1,2-dihydroxy cyclohexanes to 2-amino-6-(heteroaryl)cyclohexanols (and related cyclic compounds). 2. The process of wherein said compounds II and III are reacted in the presence of a chiral palladium catalyst formed from a chiral ligand and a palladium compound chosen from tris(dibenzylideneacetone)dipalladium claim 1 , bis(dibenzylideneacetone)palladium claim 1 , tetrakis(triphenylphosphine)palladium claim 1 , and allylpalladium chloride dimer.3. The process of wherein said chiral ligand is chosen from (2 claim 2 ,2′-bis(diphenylphosphino)-1 claim 2 ,1′-binaphthyl) (BINAP) claim 2 , 5 claim 2 ,5′-bis(diphenylphosphino)-4 claim 2 ,4′-bi-1 claim 2 ,3-benzodioxole (SEGPHOS) claim 2 , 1 claim 2 ,2-diaminocyclohexane-N claim 2 ,N′-bis(2-diphenylphosphinobenzoyl) (DACH-phenyl) claim 2 , and 1 claim 2 ,2-diaminocyclohexane-N claim 2 ,N′-bis(2-diphenylphosphino-1-naphthoyl) (DACH-naphthyl).4. (canceled)5. (canceled)7. (canceled)8. (canceled)9. (canceled)10. (canceled)11. The process of wherein said azide of formula VI is reduced to a rel-(1S claim 6 ,2S claim 6 ,6R)-2-amino-6-(heteroaryl)cyclohexanol of formula V using triphenyl phosphine.12. The process of wherein both of rings T and U are benzene.13. The process of wherein both of rings T and U are benzene.14. The process of claim 1 , wherein Q is chosen from —CH— claim 1 , —O— claim 1 , —N(Boc)- claim 1 , —N(Cbz)- claim 1 , —N(CH)— claim 1 , and —N(Ac)—.15. The process of wherein Q is chosen from —CH— claim 6 , —O— claim 6 , —N(Boc)- claim 6 , —N(Cbz)- claim 6 , —N(CH)— ...

GREEN LIGHT THERMALLY ACTIVATED DELAYED FLUORESCENT MATERIAL AND SYNTHESIZING METHOD THEREOF, AND ELECTROLUMINESCENT DEVICE

A green light thermally activated delayed fluorescent material and a synthesizing method thereof, and an electroluminescent device are described. The green light thermally activated delayed fluorescent material is a target compound reacted and synthesized by an electron donor and an electron acceptor. The target compound is a D-A molecular structure. The electron acceptor has a fluorine-containing group and a bromine-containing group. The electron acceptor is a planar electron acceptor with an ultra-low triplet state energy level, and a triplet state energy level of the target compound ranges from 1.0 to 2.0 eV. The synthesized green light thermally activated delayed fluorescent material improves a luminous efficiency and realizes a preparation of a high efficiency organic electroluminescent device. 1. A green light thermally activated delayed fluorescent material , which is a target compound reacted and synthesized by an electron donor and an electron acceptor , wherein the target compound is a D-A molecular structure ,wherein, in the D-A molecular, the D is the electron donor, the A is the electron acceptor, the electron acceptor has a fluorine-containing group and a bromine-containing group, the electron acceptor is a planar electron acceptor with an ultra-low triplet state energy level, and a triplet state energy level of the target compound ranges from 1.0 to 2.0 eV.4. A synthesizing method of a green light thermally activated delayed fluorescent material , comprising:a reaction solution preparation step of placing an electron donor, an electron acceptor, and a catalyst into a reaction vessel to obtain a reaction solution;a target compound synthesis step of placing the reaction solution at a temperature from 110° C. to 130° C. to thoroughly react and thus obtain a mixed solution, wherein the mixed solution has a target compound formed after reacting;an extraction step of cooling the mixed solution to a room temperature to extract the target compound from the ...

ANTI-INFECTIVE HETEROCYCLIC COMPOUNDS AND USES THEREOF

The present invention relates to heterocyclic compounds of Formula I useful as anti-infective agents. The present invention further relates to a method of treating an infection by administering such compounds, and to pharmaceutical compositions comprising such compounds. 3. A compound according to claim 1 , wherein Ris selected from the group consisting of —H claim 1 , —CF claim 1 , —N(R) claim 1 , —NHR claim 1 , —N(R)C(O)R claim 1 , and —N(R)C(S)N(R);{'sup': 2', '1', '8, 'sub': '1-3', 'with the proviso that if Ris —H, then Ris not —H or —Calkyl and Ris not H.'}4. A compound according to claim 1 , wherein Ris not H.5. A compound according to claim 1 , wherein X claim 1 , X claim 1 , X claim 1 , Xand Xare C.6. A compound according to claim 1 , wherein Ris H.7. A compound according to claim 1 , wherein Ris selected from the group consisting of —NHand —NHR.8. A compound according to claim 1 , wherein Ris —NHC(O)R.9. A compound according to claim 1 , wherein Ris H.10. A compound according to claim 1 , wherein Ris H.11. A compound according to claim 1 , wherein A is S.12. A compound according to claim 1 , wherein Ris selected from the group consisting of —CFand -indolyl.13. (canceled)14. (canceled)15. (canceled)16. (canceled)17. (canceled)18. A method of treating an infection which comprises administering to a patient in need thereof a therapeutically effective amount of a compound according to claim 1 , or a pharmaceutically acceptable salt thereof.19. The method according to claim 18 , wherein the infection is a bacterial claim 18 , fungal claim 18 , or parasitic infection.20Staphylococcus, Enterococcus, Streptococcus, Pseudomonas, Legionella, Klebsiella, Haemophilus, Neisseria, Listeria, EscherichiaMycobacterium.. The method according to claim 19 , wherein the infection is a bacterial infection caused or complicated by bacteria of a genus selected from and21S. aureus, E. faecalis, E. faecium, S. pneumoniae, E. coli, K. pneumoniae, H. influenza, A. baumannii, P. ...

POLYCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME

A polycyclic compound and an organic light-emitting device including the same are provided. The polycyclic compound is represented by Formula : 2. The polycyclic compound of claim 1 , wherein claim 1 ,in Formulae 2 and 3,{'sub': 11', '31', '32', '21', '22', '31, 'Yis selected from a single bond, C(R)(R), O, and S, and at least one of Yor Yis N(R).'}3. The polycyclic compound of claim 1 , wherein claim 1 ,in Formulae 2 to 4,{'sub': 1', '11', '21, 'L, L, and Lare each independently selected froma phenylene group, a pentalenylene group, an indenylene group, a naphthylene group, an azulenylene group, a heptalenylene group, an indacenylene group, an acenaphthylene group, a fluorenylene group, a spiro-bifluorenylene group, a spiro-fluorene-benzofluorenylene group, a benzofluorenylene group, a dibenzofluorenylene group, a phenalenylene group, a phenanthrenylene group, an anthracenylene group, a fluoranthenylene group, a triphenylenylene group, a pyrenylene group, a chrysenylene group, a naphthacenylene group, a picenylene group, a perylenylene group, a pentaphenylene group, a hexacenylene group, a pentacenylene group, a rubicenylene group, a coronenylene group, an ovalenylene group, a pyrrolylene group, a thiophenylene group, a furanylene group, an imidazolylene group, a pyrazolylene group, a thiazolylene group, an isothiazolylene group, an oxazolylene group, an isoxazolylene group, a pyridinylene group, a pyrazinylene group, a pyrimidinylene group, a pyridazinylene group, an isoindolylene group, an indolylene group, an indazolylene group, a purinylene group, a quinolinylene group, an isoquinolinylene group, a benzoquinolinylene group, a phthalazinylene group, a naphthyridinylene group, a quinoxalinylene group, a quinazolinylene group, a cinnolinylene group, a carbazolylene group, a phenanthridinylene group, an acridinylene group, a phenanthrolinylene group, a phenazinylene group, a benzimidazolylene group, a benzofuranylene group, a benzothiophenylene group, an ...

PHENOXAZINE DERIVATIVES FOR ORGANIC ELECTROLUMINESCENT DEVICES

The present invention relates to the compounds of the formulae (1) and (2) and to organic electroluminescent devices, in particular blue-emitting devices, in which these compounds are used as host material or dopant in the emitting layer and/or as hole-transport material and/or as electron-transport material. 116-. (canceled)19. The compound of claim 17 , wherein a+c=1 and b+d=0 or b+d=1 and a+c=0.20. The compound of claim 17 , wherein Ar is an aromatic or heteroaromatic ring system having 5 to 18 aromatic ring atoms.21. The compound of claim 17 , wherein Ar is selected from the group consisting of phenyl claim 17 , fluorenyl claim 17 , spirobifluorenyl claim 17 , benzofluorenyl claim 17 , biphenyl claim 17 , terphenyl claim 17 , quaterphenyl claim 17 , naphtyl claim 17 , anthracyl claim 17 , phenanthryl claim 17 , chrysenyl claim 17 , and pyrenyl claim 17 , wherein each of which is optionally substituted by one or more radicals R.22. The compound of claim 17 , wherein Aris selected from the group consisting of naphtyl claim 17 , anthracyl claim 17 , phenanthryl claim 17 , chrysenyl claim 17 , and pyrenyl claim 17 , wherein each of which is optionally substituted by one or more radicals R.25. The compound of claim 17 , wherein E claim 17 , E claim 17 , and Eare claim 17 , on each occurrence claim 17 , identically or differently claim 17 , selected from the group consisting of C(R) claim 17 , Si(R) claim 17 , O claim 17 , N claim 17 , S claim 17 , and groups of formula (E-1).26. The compound of claim 17 , wherein R claim 17 , R claim 17 , R claim 17 , and Rare selected claim 17 , identically or differently on each occurrence claim 17 , from the group consisting of H claim 17 , D claim 17 , F claim 17 , CN claim 17 , a straight-chain alkyl group having 1 to 20 C atoms or a branched or cyclic alkyl group having 3 to 20 C atoms claim 17 , wherein the above-mentioned groups are each optionally substituted by one or more radicals Rand wherein one or more CHgroups in the ...

ORGANIC LIGHT-EMITTING DIODE MATERIALS

Described herein are molecules for use in organic light emitting diodes. Example molecules comprise at least one acceptor moiety A, at least one donor moiety D, and optionally one or more bridge moieties B. Each moiety A is covalently attached to either the moiety B or the moiety D, each moiety D is covalently attached to either the moiety B or the moiety A, and each moiety B is covalently attached to at least one moiety A and at least one moiety D. Values and preferred values of moieties A, D, and B are defined herein. 2. The molecule of claim 1 , wherein:{'sup': 1', '2, 'sub': 6', '12, 'Rand Rare, each independently, H or C-Caryl; and'}p is 1.4. The molecule of any one of to claim 1 , wherein:{'sub': 1', '2, 'Fand Fare, each independently, a CR′.'}5. The molecule of any one of to claim 1 , wherein q is 0.10. A molecule comprising:at least one moiety A;at least one moiety D; andoptionally, one or more moiety B, wherein each moiety B is multivalent;wherein moieties A are different from moieties D;wherein each moiety A is covalently attached to either at least one of the moieties B or at least one moiety D;wherein each moiety D is covalently attached to either at least one of the moieties B or at least one moiety A;wherein each moiety B is covalently attached to at least one of the moieties A and at least one of the moieties D;wherein the moiety A, for each occurrence independently, is selected from List A1, List A2, List A3, or any combination thereof;wherein the moiety D, for each occurrence independently, is selected from List D1, List D2, List D3, or any combination thereof;wherein each moiety B, for each occurrence independently, is selected List B1, List B2, or both; andwherein the molecule is represented by any one of the structural formulas in Tables 1-14,{'sub': 1', '6', '6', '12', '2', '2, 'sup': 19', '20, 'wherein the carbon or heteroatom denoted by (*) in the structural formulas represented in Tables 1-14 is unsubstituted or substituted by a C-Calkyl, —OH ...

SPIROBIFLUORENE COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT DEVICES

The present invention relates to compounds of the formula (1) which are suitable for use in electronic devices, in particular organic electroluminescent devices, and to electronic devices which comprise these compounds. 115-. (canceled)17. A process for the preparation of the compound according to comprising introducing the diarylamino group by a C—N coupling reaction between a 1- or 3- or 4-halogenated spirobifluorene and a diarylamine.18. A method comprising utilizing the compound according to in an electronic device.19. An electronic device comprising at least one compound according to claim 16 , selected from the group consisting of organic electroluminescent devices claim 16 , organic integrated circuits claim 16 , organic field-effect transistors claim 16 , organic thin-film transistors claim 16 , organic light-emitting transistors claim 16 , organic solar cells claim 16 , organic dye-sensitised solar cells claim 16 , organic optical detectors claim 16 , organic photoreceptors claim 16 , organic field-quench devices claim 16 , light-emitting electrochemical cells claim 16 , organic laser diodes and organic plasmon emitting devices.20. The electronic device according to claim 19 , selected from organic electroluminescent devices claim 19 , wherein the at least one compound according is comprised as hole-transport material in a hole-transport or hole-injection or exciton-blocking or electron-blocking layer claim 19 , or is comprised as matrix material for fluorescent or phosphorescent emitters in an emitting layer. The present invention relates to materials for use in electronic devices, in particular in organic electroluminescent devices, and to electronic devices comprising these materials.The structure of organic electroluminescent devices (OLEDs) in which organic semiconductors are employed as functional materials is described, for example, in U.S. Pat. Nos. 4,539,507, 5,151,629, EP 0676461 and WO 98/27136. The emitting materials employed here are ...

ORGANIC ELECTROLUMINESCENT MATERIAL AND ORGANIC OPTOELECTRONIC DEVICE

A compound and an organic optoelectronic device are provided. The compound has the following chemical formula (I): 7. The compound according to claim 1 , wherein:{'sub': 6', '30, 'Cto Caryl is selected from phenyl and naphthyl.'}8. The compound according to claim 2 , wherein:{'sub': 6', '30, 'Cto Caryl is selected from phenyl and naphthyl.'}10. The compound according to claim 1 , wherein:{'sub': 1', '1, 'an energy difference between a lowest singlet excited slate Sand a lowest triplet excited state Tof the organic electroluminescent compound is configured to be ΔEst, wherein ΔEst≦0.30 eV.'}11. The compound according to claim 10 , wherein:{'sub': 1', '1, 'the energy difference between the lowest singlet excited state Sand the lowest triplet excited state Tof the organic electroluminescent compound is configured to be ΔEst, wherein ΔEst≦0.02 eV.'}13. The organic optoelectronic device according to claim 12 , wherein:the one or more organic electroluminescent compounds are heat activated delayed fluorescence (TADF) materials.14. The organic optoelectronic device according to claim 12 , wherein:the at least one of the one or more organic thin film layers disposed between the anode and the cathode is a light-emitting layer, wherein the light-emitting layer includes the one or more organic electroluminescent compounds.15. The organic optoelectronic device according to claim 14 , wherein:the one or more organic electroluminescent compounds are used as a dopant material, a co-doping material, and a host material in the light-emitting layer.16. The organic optoelectronic device according to claim 12 , wherein:the one or more organic thin film layers further include at least one of a hole transport layer, a hole injection layer, an electron blocking layer, a hole blocking layer, an electron transport layer, and an electron injection layer.17. The organic optoelectronic device according to claim 16 , wherein:at least one of the hole transport layer, the hole injection layer, ...

ORGANIC ELECTROLUMINESCENT MATERIAL AND ORGANIC OPTOELECTRONIC DEVICE

A compound and an organic optoelectronic device are provided. The compound has the chemical formula (I): 2. The compound according to claim 1 , wherein:Ar is selected from N-substituted or substituted phenyl, biphenyl and fused ring aryl.3. The compound according to claim 1 , wherein:in is an integer, and 1≦m≦2; andn is an integer, and 1≦n≦4.9. The compound according to claim wherein:{'sub': 1', '1, 'an energy difference between a lowest singlet excited state Sand a lowest triplet excited state Tof the compound is configured to be ΔEst, wherein ΔEst≦0.30 eV.'}10. The compound according to claim 10 , wherein:{'sub': 1', '1, 'the energy difference between the lowest singlet excited state Sand the lowest triplet excited state Tof the compound is configured to be ΔEst, wherein ΔEst≦0.02 eV.'}12. The organic optoelectronic device according to claim 11 , wherein:the one or more compounds are heat activated delayed fluorescence (TADF) materials,13. The organic optoelectronic device according to claim 11 , wherein:the at least one of the one or more organic thin film layers disposed between the anode and the cathode is a light-emitting layer, wherein the light-emitting layer includes the one or more compounds.14. The organic optoelectronic device according to claim 13 , wherein:the one or more compounds are used as a dopant material, a co-doping material, or a host material in the light-emitting layer.15. The organic optoelectronic device according to claim 11 , wherein:the one or more organic thin film layers further include at least one of a hole transport layer, a hole injection layer, an electron blocking layer, a hole blocking layer, an electron transport layer, and an electron injection layer.16. The organic optoelectronic device according to claim 11 , wherein:at least one of the hole transport layer, the hole injection layer, the electron blocking layer, the hole blocking layer, the electron transport layer, and the electron injection layer includes the one or more ...

DOPANT FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE

The present invention relates to: a dopant for an organic optoelectronic device, represented by chemical formula 1; an organic optoelectronic device including the dopant; and a display device. 2. The dopant for an organic optoelectronic device of claim 1 , wherein:{'sup': 1', '2, 'at least one of Wor Wis the substituted or unsubstituted aromatic heterocyclic group having at least one nitrogen, and'}the substituted or unsubstituted aromatic heterocyclic group having at least one nitrogen is selected from a substituted or unsubstituted triazinyl group; a substituted or unsubstituted pyrimidinyl group; a substituted or unsubstituted pyridinyl group; a substituted or unsubstituted quinazolinyl group; a substituted or unsubstituted quinoxalinyl group; or a combination thereof.3. The dopant for an organic optoelectronic device of claim 2 , wherein the substituted or unsubstituted aromatic heterocyclic group having at least one nitrogen is selected from a triazinyl group substituted with a C6 to C30 aryl group or a C3 to C30 heterocyclic group; a pyrimidinyl group substituted with a C6 to C30 aryl group or a C3 to C30 heterocyclic group; a pyridinyl group substituted with a C6 to C30 aryl group or a C3 to C30 heterocyclic group; a quinazolinyl group substituted with a C6 to C30 aryl group or a C3 to C30 heterocyclic group; a quinoxalinyl group substituted with a C6 to C30 aryl group or a C3 to C30 heterocyclic group; or a combination thereof.6. The dopant for an organic optoelectronic device of claim 5 , wherein Ris hydrogen or the same as Wand Ris hydrogen or the same as W.7. The dopant for an organic optoelectronic device of claim 6 , wherein{'sup': '2', 'Ris hydrogen or the group represented by Chemical Formula B, and'}{'sup': '4', 'Ris hydrogen or the group represented by Chemical Formula B.'}10. The dopant for an organic optoelectronic device of claim 1 , wherein the dopant is a fluorescent dopant having an energy gap between singlet energy and triplet energy of less ...

Organic electroluminescent material

The present invention discloses an organic electronic luminescent material, with the chemical formula (I). The compounds having the chemical formula (I) in the present invention have highly stable electron-withdrawing groups and electron-donating groups with stable chemical bonds between them but without a strong conjugation. With these features, the compounds with the formula (I) have high fluorescence quantum efficiency and excellent charge transport ability. These compounds are closer to the dark color of international standard, which is conducive to achieve full color displays with higher color purity.

CONTROLLING ZONES OF ELECTRONIC DEVICES ASSOCIATED WITH POWER LINES

Methods, systems, and apparatus for monitoring and controlling electronic devices using wired and wireless protocols are disclosed. The systems and apparatus may monitor their environment for signals from electronic devices. The systems and apparatus may take and disambiguate the signals that are received from the devices in their environment to identify the devices and associate control signals with the devices. The systems and apparatus may use communication means to send control signals to the identified electronic devices. Multiple apparatuses or systems may be connected together into networks, including mesh networks, to make for a more robust architecture.

CONJUGATED COMPOUND CONTAINING BIS(PHENYLSULFONYL)BENZENE STRUCTURE, PREPARATION METHOD AND APPLICATION THEREOF

The invention provides a conjugated compound containing a bis(phenylsulfonyl)benzene structure, a preparation method and an application thereof, the compound includes a chemical structure with one of structural general formulas as follows: 4. The preparation method of the conjugated compound containing a bis(phenylsulfonyl)benzene structure as claimed in claim 3 , wherein the step 10 concretely comprises following steps:step 11, dissolving a halogenated thiophenol and a dichloro-dicyano-p-benzoquinone (DDQ) in a solvent, heating to react, and thereby obtaining a halogenated diphenyl disulfide;step 12, dissolving the halogenated diphenyl disulfide, a dihalogeno-benzene, a catalyst and an alkali in a solvent, heating to react and thereby obtaining a halogen-substituted bis(phenylsulfenyl)benzene;step 13, dissolving the halogen-substituted bis(phenylsulfenyl)benzene in a solvent, adding an oxidizer, heating to react and thereby obtaining the halogen-substituted bis(phenylsulfonyl)benzene.5. The preparation method of the conjugated compound containing a bis(phenylsulfonyl)benzene structure as claimed in claim 4 , wherein the step concretely is that dissolving the synthesized halogen-substituted bis(phenylsulfonyl)benzene claim 4 , the borate ester of the Ar unit claim 4 , the catalyst and the alkali in a solvent claim 4 , heating to react and thereby obtaining the conjugated compound containing a bis(phenylsulfonyl)benzene structure;{'sub': '2', 'the step 20′ concretely is that dissolving the synthesized halogen-substituted bis(phenylsulfonyl)benzene, the NH(Ar)compound containing secondary amine atoms, the catalyst and the alkali in a solvent, heating to react and thereby obtaining the conjugated compound containing a bis(phenylsulfonyl)benzene structure.'}6. The preparation method of the conjugated compound containing a bis(phenylsulfonyl)benzene structure as claimed in claim 5 , wherein:in the step 11, a molar ratio of the halogenated thiophenol to the dichloro- ...

HETEROCYCLIC COMPOUNDS FOR USE IN ELECTRONIC DEVICES

The present invention relates to heterocyclic compounds and to electronic devices, especially organic electroluminescent devices, comprising these compounds. 123.-. (canceled)27. The compound according to claim 24 , wherein the two Rradicals bonded to the carbon atom in position 9 in the fluorene structure of formula (IIa) or (IIb) are each an aromatic or heteroaromatic ring system which has 5 to 30 aromatic ring atoms and may be substituted by one or more Rradicals claim 24 , where the two ring systems are joined to one another.29. The compound according to claim 24 , wherein the two Rradicals bonded to the carbon atom in position 9 in the fluorene structure of formula (IIa) or (IIb) are each an aromatic or heteroaromatic ring system which has 5 to 30 aromatic ring atoms and may be substituted by one or more Rradicals claim 24 , where the two ring systems are not joined to one another claim 24 , or a straight-chain alkyl claim 24 , alkoxy or thioalkoxy group having 1 to 40 carbon atoms or a branched or cyclic alkyl claim 24 , alkoxy or thioalkoxy group having 3 to 40 carbon atoms claim 24 , each of which may be substituted by one or more Rradicals claim 24 , where one or more nonadjacent CHgroups may be replaced by —RC═CR— claim 24 , —C≡C— claim 24 , Si(R) claim 24 , C═O claim 24 , C═S claim 24 , C═NR claim 24 , —C(═O)O— claim 24 , —C(═O)NR— claim 24 , NR claim 24 , P(═O)(R) claim 24 , —O— claim 24 , —S— claim 24 , SO or SOand where one or more hydrogen atoms may be replaced by D claim 24 , F claim 24 , Cl claim 24 , Br claim 24 , I claim 24 , CN or NO.31. The compound according to claim 24 , wherein claim 24 , in formulae (I) claim 24 , (Ib) claim 24 , (IIa) claim 24 , (IIb) claim 24 , (IIc) claim 24 , (IId) claim 24 , (IIe) and formula (IIf) claim 24 , not more than two and preferably not more than one X group is N claim 24 , and preferably all X are CR claim 24 , where preferably at most 4 claim 24 , more preferably at most 3 and especially preferably at most 2 ...

Compound and organic photoelectric device, image sensor and electronic device including the same

A compound of Chemical Formula 1, and an organic photoelectric device, an image sensor, and an electronic device including the same are disclosed: In Chemical Formula 1, each substituent is the same as defined in the detailed description.

DDR2 INHIBITORS AND METHODS OF USING

Compounds that inhibit activation of Discoidin Domain Receptor 2 (DDR2) and methods of using the compounds to inhibit DDR2 activation, inhibit migration of cells expressing DDR2, and treat diseases or disorders associated with DDR2 dysfunction. 2. The compound of claim 1 , wherein Ris phenyl claim 1 , substituted phenyl claim 1 , naphthyl claim 1 , substituted naphthyl claim 1 , furyl claim 1 , substituted furyl claim 1 , benzofuryl claim 1 , substituted benzofuryl claim 1 , oxazolyl claim 1 , substituted oxazolyl claim 1 , isoxazolyl claim 1 , substituted isoxazolyl claim 1 , oxadiazolyl claim 1 , substituted oxadiazolyl claim 1 , benzoxazolyl claim 1 , substituted benzoxazolyl claim 1 , benzoxadiazolyl claim 1 , substituted benzoxadiazolyl claim 1 , pyrrolyl claim 1 , substituted pyrrolyl claim 1 , pyrazolyl claim 1 , substituted pyrazolyl claim 1 , imidazolyl claim 1 , substituted imidazolyl claim 1 , triazolyl claim 1 , substituted triazolyl claim 1 , tetrazolyl claim 1 , substituted tetrazolyl claim 1 , pyridyl claim 1 , substituted pyridyl claim 1 , pyrimidyl claim 1 , substituted pyrimidyl claim 1 , pyrazinyl claim 1 , substituted pyrazinyl claim 1 , pyridazinyl claim 1 , substituted pyridazinyl claim 1 , piperidyl claim 1 , substituted piperidyl claim 1 , indolyl claim 1 , substituted indolyl claim 1 , isoindolyl claim 1 , substituted isoindolyl claim 1 , indolizinyl claim 1 , substituted indolizinyl claim 1 , morpholyl claim 1 , substituted morpholyl claim 1 , benzimidazolyl claim 1 , substituted benzimidazolyl claim 1 , indazolyl claim 1 , substituted indazolyl claim 1 , benzotriazolyl claim 1 , substituted benzotriazolyl claim 1 , tetrazolopyridazinyl claim 1 , substituted tetrazolopyridazinyl claim 1 , carbazolyl claim 1 , substituted carbazolyl claim 1 , purinyl claim 1 , substituted purinyl claim 1 , quinolinyl claim 1 , substituted quinolinyl claim 1 , isoquinolinyl claim 1 , substituted isoquinolinyl claim 1 , imidazopyridyl claim 1 , or substituted ...

COMPOUND, DISPLAY PANEL, AND DISPLAY APPARATUS

Provided is a host material compound having a structure represented by Formula (I): 13. A display panel , comprising an organic light-emitting device , wherein the organic light-emitting device comprises an anode , a cathode disposed oppositely to the anode , and a light-emitting layer disposed between the anode and the cathode , whereinthe light-emitting layer comprises a host material and a guest material, and{'claim-ref': {'@idref': 'CLM-00001', 'claim 1'}, 'the host material is one or more compounds according to .'}141111. The display panel according to claim 13 , wherein a singlet energy level S of the host material is higher than a singlet energy level S of the guest material claim 13 , and an energy difference between the singlet energy level S of the host material and the singlet energy level S of the guest material is less than 0.8 eV claim 13 , and{'b': 1', '1', '1', '1, 'wherein a triplet energy level T of the host material is higher than a triplet energy level T of the guest material, and an energy difference between the triplet energy level T of the host material and the triplet energy level T of the guest material is less than 0.4 eV.'}151. The display panel according to claim 13 , wherein when the host material of the light-emitting layer is a red-light-emitting material claim 13 , a triplet energy level T of the red-light-emitting material has a lowest value as 2.2 eV;{'b': '1', 'when the host material of the light-emitting layer is a green-light-emitting material, a triplet energy level T of the green-light-emitting material has a lowest value as 2.5 eV; and'}{'b': '1', 'when the host material of the light-emitting layer is a blue-light-emitting material, a triplet energy level T of the blue-light-emitting material has a lowest value as 2.7 eV.'}16. The display panel according to claim 13 , wherein the organic light-emitting device comprises:a capping layer, and the capping layer is disposed on a side of the cathode facing away from the anode;at ...

NEAR-INFRARED FLUORESCENT NERVE CONTRAST AGENTS AND METHODS OF USE THEREOF

The instant invention provides near-infrared fluorescent nerve contrast agents and methods of using them. 2. The method of claim 1 , wherein the tissue or cells is nerve tissue or nerve cells.3. The method of claim 1 , wherein X is O.4. The method of claim 1 , wherein the compound is selected from the group consisting of Oxazine 1 claim 1 , Oxazine 4 claim 1 , Oxazine 170 claim 1 , Oxazine 750 and Rhodamine 800.5. The method of claim 1 , wherein the compound is selected from the group consisting of ESNF-35 claim 1 , ESNF-36 claim 1 , ESNF-37 claim 1 , ESNF-38 claim 1 , ESNF-39 claim 1 , ESNF-40 claim 1 , ESNF-41 and ESNF-42.6. The method of claim 1 , wherein the compound is TG17 claim 1 , TG18 claim 1 , TG20 claim 1 , or CNN13.7. The method of claim 1 , wherein the imaging agent is administered to an organism comprising the tissue or cells.8. The method of claim 7 , wherein the organism is human.9. The method of claim 1 , wherein Mis ClO.10. The method of claim 1 , wherein the imaging agent has peak absorbance at about 600 nm to 850 nm.11. The method of where the imaging agent comprises a radioisotope for positron emission tomography.13. The compound of claim 12 , wherein R claim 12 , R claim 12 , R claim 12 , R claim 12 , Rand Rare each independently H claim 12 , methyl or ethyl.14. The compound of claim 12 , wherein one of R claim 12 , Rand Ris OH.15. The compound of claim 12 , wherein the compound is selected from the group consisting of ESNF-35 claim 12 , ESNF-36 claim 12 , ESNF-37 claim 12 , ESNF-38 claim 12 , ESNF-39 claim 12 , ESNF-40 claim 12 , ESNF-41 and ESNF-42.16. The compound of claim 12 , wherein the compound is TG17 claim 12 , TG18 claim 12 , TG20 claim 12 , or CNN13.17. A pharmaceutical composition comprising a compound of and a pharmaceutically acceptable carrier.18. The method of claim 1 , wherein the imaging agent is selectively absorbed by nerve tissue or nerve cells and the selectivity is at least 2:1 relative to muscle cells.19. The method of ...

Light-emitting material, organic light-emitting device, and compound

A compound represented by the general formula (11) is useful as a light-emitting material. R 1 , R 2 , R 4 and R 5 represent a group represented by the general formula (2), R 11 to R 20 represent a hydrogen atom or a substituent, and L 12 represents a substituted or unsubstituted arylene group or a substituted or unsubstituted heteroarylene group.

LIGHT-EMITTING MATERIAL, ORGANIC LIGHT-EMITTING DEVICE, AND COMPOUND

A compound represented by the general formula (1) is useful as a light-emitting material. In the general formula (1), from 0 to 1 of Rto Rrepresents a cyano group, from 1 to 5 of Rto Rrepresent a group represented by the general formula (2) etc., and the balance of Rto Rrepresent a hydrogen atom or a substituent other than above. Rto Rrepresent a hydrogen atom or a substituent, Lrepresents a substituted or unsubstituted arylene group or a substituted or unsubstituted heteroarylene group. 3. The light-emitting material according to claim 1 , wherein in the general formula (1) claim 1 , Rrepresents a cyano group.4. The light-emitting material according to claim 1 , wherein in the general formula (1) claim 1 , Rand Reach represent a group represented by the general formula (2).5. The light-emitting material according to claim 1 , wherein in the general formula (2) claim 1 , Lrepresents a phenylene group.6. The light-emitting material according to claim 1 , wherein the group represented by the general formula (2) is a group represented by the general formula (3).7. The light-emitting material according to claim 6 , wherein in the general formula (3) claim 6 , Lrepresents a 1 claim 6 ,3-phenylene group.8. The light-emitting material according to claim 1 , wherein the group represented by the general formula (2) is a group represented by the general formula (4).9. The light-emitting material according to claim 8 , wherein in the general formula (4) claim 8 , Lrepresents a 1 claim 8 ,4-phenylene group.10. The light-emitting material according to claim 1 , wherein the group represented by the general formula (2) is a group represented by the general formula (8).11. The light-emitting material according to claim 10 , wherein in the general formula (8) claim 10 , L represents a 1 claim 10 ,4-phenylene group.12. The light-emitting material according to claim 1 , wherein in the general formula (1) claim 1 , Rrepresents a group that satisfies the following condition A claim 1 , ...

REDUNDANT POWER LINE CONTROL SYSTEMS

Methods, systems, and apparatus for monitoring and controlling electronic devices using wired and wireless protocols are disclosed. The systems and apparatus may monitor their environment for signals from electronic devices. The systems and apparatus may take and disambiguate the signals that are received from the devices in their environment to identify the devices and associate control signals with the devices. The systems and apparatus may use communication means to send control signals to the identified electronic devices. Multiple apparatuses or systems may be connected together into networks, including mesh networks, to make for a more robust architecture. 1. A system for controlling an electronic device located at a site , comprising: a memory; and', receiving device signal information, signal noise, a conflated device signal, or a combination thereof, from a circuit connected to the control apparatus and the electronic device;', 'identifying the electronic device by comparing the device signal information, the signal noise, the conflated device signal, or a combination thereof, to a device waveform associated with the electronic device;', 'establishing a communication link with the electronic device; and', 'transmitting a control signal for controlling the electronic device via the communication link., 'a processor coupled to the memory, wherein the processor performs operations comprising], 'a control apparatus, comprising2. The system of claim 1 , wherein the operations further comprise receiving power via the circuit.3. The system of claim 1 , wherein the operations further comprise associating a device control pathway with the electronic device.4. The system of claim 1 , wherein the operations further comprise generating the control signal for controlling the electronic device.5. The system of claim 1 , wherein the operations further comprise pinging all inputs available to a communications cube of the control apparatus.6. The system of claim 1 , wherein ...

METHODS AND SYSTEMS FOR WIRELESS TO POWER LINE COMMUNICATION

Methods, systems, and apparatus for monitoring and controlling electronic devices using wired and wireless protocols are disclosed. The systems and apparatus may monitor their environment for signals from electronic devices. The systems and apparatus may take and disambiguate the signals that are received from the devices in their environment to identify the devices and associate control signals with the devices. The systems and apparatus may use communication means to send control signals to the identified electronic devices. Multiple apparatuses or systems may be connected together into networks, including mesh networks, to make for a more robust architecture. 1. A system for communicating with one or more electronic devices , comprising: a processor;', 'a memory coupled to the processor; and', 'a control clamp coupled to the processor, the control clamp being configured to splice into a power line to disrupt electrical power through the power line while simultaneously redirecting electrical power from the power line through the control apparatus and to the electronic devices;, 'a control apparatus, wherein the control apparatus comprises establish a power line communication link between one or more of the electronic devices and the processor; and', 'establish a wireless communication link between a remote device and the processor;, 'wherein the control apparatus is configured towherein the control apparatus is configured to relay at least one communication between the power line communication link and the wireless communication link.2. The apparatus of claim 1 , wherein the control apparatus is configured to monitor and control at least one of the electronic devices through the control clamp of the control apparatus.3. The apparatus of claim 1 , wherein the control apparatus is configured to establish an additional power line communication link between at least one additional control apparatus coupled to the power line and the processor.4. The apparatus of claim ...

CONTROLLING ZONES OF ELECTRONIC DEVICES ASSOCIATED WITH POWER LINES

Methods, systems, and apparatus for monitoring and controlling electronic devices using wired and wireless protocols are disclosed. The systems and apparatus may monitor their environment for signals from electronic devices. The systems and apparatus may take and disambiguate the signals that are received from the devices in their environment to identify the devices and associate control signals with the devices. The systems and apparatus may use communication means to send control signals to the identified electronic devices. Multiple apparatuses or systems may be connected together into networks, including mesh networks, to make for a more robust architecture. 1. A system for controlling electronic devices , comprising: a processor;', 'a memory coupled to the processor; and', 'wherein the control apparatus is configured to couple to at least one conductor in a power line associated with an electronic device receiving power from the power line, and wherein the control apparatus is configured to redirect electrical power from the at least one conductor through the control apparatus and to the electronic device;, 'a plurality of control apparatus, wherein one or more of the control apparatus comprisewherein one or more control apparatus are configured to be coupled to one or more electronic devices located at a site; andat least one remote device, the at least one remote device being configured to establish a wireless communication link to one or more of the control apparatus; determine a control apparatus having a strongest wireless communication link with the remote device; and', 'establish a communication link between the control apparatus having the strongest wireless communication link and one or more additional control apparatus;', 'wherein the control apparatus having the strongest wireless communication link is configured to relay communications between at least one of the additional control apparatus and the remote device., 'wherein system is configured to2. ...

Azulene ring-containing compound, its use, and an organic photoelectric device including the same

The present disclosure provides an azulene ring-containing compound, its use, and an organic photoelectric device including the same. The azulene ring-containing compound is a compound comprising a structure of Formula I. The organic photoelectric device includes an anode, a cathode, and one or more organic thin film layers located between the anode and the cathode; and at least one of the organic thin film layers contains the above-mentioned azulene ring-containing compound comprising the structure of Formula I. The azulene ring-containing compound provided by the present disclosure has an energy level difference ΔEst≤0.3 eV between the lowest singlet state Sand the lowest triplet state T, and has a light-emitting mechanism of a thermally activated delayed fluorescent material, and can be used as a thermally activated delayed fluorescent material for organic photoelectric device, so that the light-emitting efficiency of the device is improved. 2. The azulene ring-containing compound according to claim 1 , wherein the Z ring in Formula I is a benzene ring claim 1 , a thiophene ring claim 1 , a furan ring claim 1 , or a pyridine ring.7. The azulene ring-containing compound according to claim 1 , wherein D is an electron-donating group containing nitrogen.15. The azulene ring-containing compound according to claim 1 , wherein the azulene ring-containing compound has an energy level difference ΔE=E−EeV between the lowest singlet state energy level Sand the lowest triplet state energy level T.16. The use of an azulene ring-containing compound according to claim 1 , wherein the azulene ring-containing compound is used as a thermally activated delayed fluorescent material.17. An organic photoelectric device claim 1 , wherein the organic photoelectric device includes an anode claim 1 , a cathode claim 1 , and one or more organic thin film layers located between the anode and the cathode;{'claim-ref': {'@idref': 'CLM-00001', 'claim 1'}, 'and at least one of the organic thin ...

Novel ester compound and pin1 inhibitor, inflammatory disease therapeutic, and colon cancer therapeutic in which said ester compound is used

An object of the present invention is to develop a therapeutic agent for an inflammatory disease such as an inflammatory bowel disease or NASH, which therapeutic agent shows less side effects and high effectiveness. The present invention provides a compound represented by Formula (I) or a salt thereof; and a Pin1 inhibitor, a pharmaceutical composition, a therapeutic agent or a prophylactic agent for an inflammatory disease, and a therapeutic agent or a prophylactic agent for colon cancer, containing the compound.

PHENANTHRENE COMPOUNDS FOR ORGANIC ELECTRONIC DEVICES

The invention relates to specific phenanthrenes, the use of the compound in an electronic device, and an electronic device containing at least one of said compounds. The invention further relates to a method for producing the compound and a formulation and composition containing one or more of the compounds. 117.-. (canceled)24. The compound according to claim 23 , wherein Y is C(R)or NR.25. The compound according to claim 18 , wherein L is a single bond claim 18 , so that the amine group is bonded directly to the phenanthrene.26. The compound according to claim 18 , wherein the compound contains in total at least 26 ring atoms.27. The compound according to claim 18 , wherein the compound contains only one amine group.28. A process for the preparation of the compound according to which comprises a one-step Buchwald coupling by reaction of a phenanthrene derivative which contains a leaving group with Ar—NH—Ar.29. A process for the preparation of the compound according to which comprises a two-step Buchwald coupling by stepwise reaction of a phenanthrene derivative which contains a leaving group with (1) Ar—NHand (2) NH—Ar.30. An oligomer claim 18 , polymer or dendrimer containing one or more compounds according to claim 18 , where the bond(s) to the polymer claim 18 , oligomer or dendrimer is optionally localized at any positions in formula (1) which are substituted by R claim 18 , Ror R.31. A composition comprising one or more compounds according to and at least one further organically functional material selected from the group consisting of fluorescent emitters claim 18 , phosphorescent emitters claim 18 , host materials claim 18 , matrix materials claim 18 , electron-transport materials claim 18 , electron-injection materials claim 18 , hole-conductor materials claim 18 , hole-injection materials claim 18 , electron-blocking materials and hole-blocking materials.32. A formulation comprising at least one compound according to and at least one solvent.33. An ...

Crosslinkable arylamine compounds and conjugated oligomers of polymers based thereon

Crosslinkable arylamine compounds; oligomers and polymers prepared from such crosslinkable arylamine compounds; films and coatings; and multilayer electronic devices comprising such films are disclosed.

用于有机电致发光器件的材料

本发明涉及式(1)的化合物，该化合物适用于电子器件中，特别是适用于有机电致发光器件中，并且涉及含有所述化合物的电子器件。

Novel oxazine-ureas and thiazine urea chromophors as fluorescent labels

Novel urea derivatives of oxazine and thiazine chromophors have the structural formula I or II. ##STR1## wherein M is oxygen or sulfur, R 1 and R 2 are aliphatic alkyl groups or hydrogen; R 3 is hydrogen or alkyl group; R 4 is hydrogen, alkyl or amine group; R 5 is hydrogen, amine or alkyl group; X.sup.⊖ is an anion consisting of an organic (e.g. CH 3 COO.sup.⊖, CH 3 CH 2 COO.sup.⊖ and the like) or inorganic specie (e.g. Cl.sup.⊖, Br.sup.⊖, I.sup.⊖, ClO 4 .sup.⊖, SO 4 ", and the like); n is 0 to 20; Z is N═C═O, N═C═S, carboxylic, primary or secondary amine, and when n=0, Z may be ##STR2## wherein Q is hydroxyl, amino, carboxylic, sulfydryl, isocyanato, or isothiocyanato. The functional oxazine-urea and thiazine-urea derivatives react with compounds of interest to form adducts resulting in the fluorescent labeling of the compound.

리간드 화합물, 전이금속 화합물 및 이를 포함하는 촉매 조성물

본 발명은 신규한 리간드 화합물, 전이금속 화합물, 및 이를 포함하는 촉매 조성물을 제공한다.

一种有机化合物及其应用及采用该化合物的有机电致发光器

本发明涉及有机电致发光技术领域，特别涉及一种有机化合物及其应用以及包含该化合物的有机电致发光器件，具体涉及一种新型热活化延迟荧光材料，具有如下式(1)的结构： 其中R 1 ‑R 6 分别独立地选自氰基、氘原子或者选自全氘取代的下述基团：取代或未取代的C3‑C60且至少含有一个氮原子的单环杂芳基、取代或未取代的C3‑C60且至少含有一个氮原子的稠环杂芳基、取代或未取代的C6‑C30芳基氨基、取代或未取代的C3‑C30杂芳基氨基中的一种，且R 1 ‑R 6 中至少有一个为氰基。本发明的化合物的优势为：作为OLED器件中的发光层材料时，具有更好的热稳定性，更高的光致发光量子效率，更快的反向系间窜跃速率，能表现出优异的器件效率和稳定性。本发明同时保护采用上述通式化合物的有机电致发光器件。